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This is a cumulative thesis that includes three different topics around male infertility in cattle 
and canine diseases. Whole genome association analysis (GWAS) and whole genome 
sequencing (WGS), as well as additional experimental approaches, were used to identify the 
candidate genes for these disorders. 
 
One of the current challenges facing the dairy industry is to predict and improve the fertility 
of bulls. We have detected a Holstein bull, who had been approved for artificial insemination 
based on his semen characteristics, but did not produce offspring after 412 first inseminations, 
resulting in a non-return rate (NR-Abw) of -29. To identify causative mutations underlying 
this idiopathic infertility, GWAS and WGS were performed on different non-return rate bulls 
followed by genotyping of candidate variants in a large population. Finally, a nonsense 
mutation (AC_000170.1: g.54429815G>A, rs468948776) in α/β-Hydrolase D16B 
(ABHD16B) on chromosome 13 was identified as a potential candidate variant. Protein 
analysis revealed expression of ABHD16B in the testes and epididymis of control bulls, and 
lipidomic analysis showed significant differences in lipid content of the plasma membrane 
between carriers and controls. We conclude that ABHD16B may play a role in lipid changes 
during spermatogenesis or sperm maturation and that the altered lipid content may explain the 
reduced fertilization capacity of mutant sperm. 
 
Hemophilia B is a monogenic, X-chromosome recessive bleeding disorder caused by genetic 
variants in the coagulation factor IX gene (F9). Here we identify a Hovawart family with 
hemophilia B Leyden caused by a deletion (NC_006621.3:g.109501492delC) in the F9 
promoter within the conserved binding region of hepatocyte nuclear factor 4α (HNF-4α) and 
androgen receptor (AR). Using EMSA we found that the deletion only eliminated the binding 
of HNF-4α to the promoter, but did not affect the binding of AR. In vitro approach utilizing 
luciferase reporter gene assay revealed a significant expression reduction of the mutated 
promoter compared to wild-type. Our results suggest that dogs provide a natural occurrence 
model for understanding hemophilia B. 
 
Congenital deafness is prevalent in many modern dog breeds, but few causative genes have 
been identified to date. Here, we attempt to find the genetic cause of congenital deafness 
around three deaf Australian Stumpy Tail Cattle Dogs (ASCD) using GWAS and WGS. A 
 
 iv 
GWAS was performed on 3 bilateral deaf ASCDs, 43 herding dogs, and one unaffected 
ASCD, resulting in the identification of 13 significantly associated loci on 6 chromosomes 
(CFA3, 8, 17, 23, 28, and 37). More than half of the significantly associated signals were 
localized on CFA37, containing the most significantly associated variant. Further WGS was 
conducted on same three deaf ASCDs and one control, whereupon a missense variant 
(NC_006619.3:g.15562684G>A; XP_022270984.1:p.Leu173Phe) of kruppel-like factor 7 
(KLF7) on CFA 37 was considered as a candidate variant. Genotyping of the KLF7 variant in 
an additional cohort of 55 ASCD samples (28 deaf and 27 normal hearing dogs) indicated that 
the variant was still associated with deafness (p = 0.014), with a calculated penetrance of 0.75. 
In conclusion, KLF7 is a promising candidate gene for the etiology of deafness in ASCD.  
 
 v 
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1 Bull fertility  
1.1 The phenotype of bull fertility  
1.1.1 Overview 
Fertility is an important economic parameter in livestock industry [1, 2]. Cattle are significant 
sources of milk and meat products for human. With the increased population and the growing 
economy, people have been pursuing high-yielding cattle breeding to meet the growing 
demand. However, the transfer to more productive cows is related to a decline in reproductive 
performance [3]. Actually, reproductive efficiency is also an important factor for dairy 
producers to pursue economic maximization. Increased reproductive capacity can raise the 
economic net returns of entire herds [4]. Therefore, many researchers began to explore the 
balance between seeking higher yield and maintaining reproductive performance [5]. In 
addition, many other factors should be considered to explain the deterioration of cattle’s 
reproductive status, such as nutrition, disease, management, inbreeding and environment 
(reviewed by Lucy [5]). 
 
The cattle genetic pool is continuously shrinking due to a high attention to limited 
economically important traits and the widespread use of a selected number of elite sires via 
artificial insemination (AI). Caraviello et al. [6] conducted a comprehensive survey of 
management practices on reproductive performance and obtained data from 103 herds. As 
expected, all of these herds predominantly used AI sires. In cattle breeding, most studies have 
focused on the fertility traits of cows, but ignored the role of bulls. Recently, more and more 
studies have appealed to increase the attention on bull fertility [7]. 
 
1.1.2 Assessment and indicator  
The potential fertility of bulls can be assessed by physical examination and phenotypic 
assessments. The fertility of bulls is affected by various factors, and no single criterion or 
diagnostic test can assess it reliably. Therefore, several measurements or indicators have been 
developed that are usually combined to predict the bull fertility. 
 
In terms of physical examination, it is generally believed that testicular characteristics and 
sperm parameters are closely related to bull fertility [8, 9]. Scrotal circumference is 
commonly used because it is a good indicator of sperm output. Scrotal size has positive 
genetic correlations with testis size and weight, sperm quantity [10] and sperm morphology 




employed in routine assessment of bull fertility, although these are only moderately correlated 
with fertility and show large ranges of variation [12]. Sperm motility is one of the most 
important characteristics associated with the fertilizing ability of bulls [13-17]. Some 
evidences suggest that abnormal sperm morphology is correlated with poor fertility [17-19]. 
However, the accuracy of morphological parameters in fertility prediction depends on the 
degree and percentage of abnormal sperm morphology [20, 21]. A breeding soundness 
evaluation (BSE) is the physical and reproductive examination for testicular development, 
sperm motility and morphology, which is the routine procedure for removal of severely 
abnormal bulls in respect of reproductive value from the herd. Some evidences suggest that 
implementation of bull BSE can improve the fertility and production performance of cattle 
[22, 23] 
 
In addition, the noncompensable traits and physiological functions of sperm are crucial for 
bull fertility evaluation. Noncompensable traits are those traits that cannot be overcome by 
increasing the number of spermatozoa in insemination [24]. Physiological functions are 
essential for spermatozoa to complete the specific process in fertilization (reviewed by 
Rodriguez-Martinez [25]). The defects of those traits may not manifest until spermatozoa-
oocyte binding, fusion or early embryo development. For example, the spermatozoic 
chromatin structure was correlated with bull fertility [26]. It is reported that the proportion of 
non-capacitated spermatozoa of frozen–thawed semen was positively correlated to fertility 
[27]. The state of acrosome reaction (AR) or the ability of sperm-zona pellucida binding is 
significantly correlated with non-return rate (NRR) [15, 28]. Several studies also 
demonstrated the paternal critical effect on developmental kinetics [29], blastocyst yield and 
quality [30, 31]. 
 
However, laboratory analysis alone is not sufficient to fully evaluate the fertility of sires. The 
bull’s accurate breeding records can provide phenotypic assessments of their own fertility. 
Several fertility endpoints between the time of insemination and the birth of offspring can 
estimate fertility including fertilization rate, NRR, and conception rate. Fertilization rate is the 
ability of sperm from a particular individual to fertilize an egg. An in vivo assessment of 
fertilization rate is flushing the uterus on day 6 or 7 after insemination to obtain the 
unfertilized ova or embryos of varying developmental stages from cows [32]. NRR, the 
percentage of cows that are not subsequently re-bred in a given interval after an insemination, 




[32, 33]. A 70-day NRR-based bull fertility assessment termed the estimated relative 
conception rate (ERCR) dates back to 1986. Since 2008, sire conception rate (SCR) based on 
confirmed pregnancy has begun to evaluate fertility of AI service-sires [34, 35]. In fact, these 
indicators from field data cannot assess 100% bull fertility, because cows, microenvironment 
and herd management have a combined impact on the outcomes [33, 36]. 
 
1.1.3 Infertility and subfertility 
Infertility in humans is defined as a couple failing to induce a pregnancy within 1 year of 
regular unprotected intercourse [37]. According to a study in 2015, the distribution of 
infertility caused by male factors ranges from 20% to 70%, and the proportion of infertile men 
ranges from 2.5% to 12% [38]. At least 15% of these infertile men are associated with genetic 
disorders that include chromosomal and single-gene aberrations [39]. Similarly, bovine 
infertility is a complex problem, manifested by decreased fertility rates, low conception rates 
and reduced embryo survival ability [5, 40]. 
 
Male infertility is a complex multifactorial disease with highly heterogeneous phenotype. It 
can be associated with congenital or acquired factors acting at pretesticular, testicular, and 
post-testicular levels [41]. The causes of male infertility vary widely including the disorders 
of hypothalamic–pituitary axis function, quantitative and qualitative problems of 
spermatogenesis, and ductal obstruction or dysfunction [42]. Among them, quantitative 
spermatogenesis defects caused by primary testicular failure, i.e. from azoospermia to 
oligozoospermia, are the most common cause (about 75%) [41, 43]. Besides, age, general and 
systemic diseases, the toxin and environmental factors as well as psychological factors all 
play important roles in male infertility. In addition, there is a large number of infertility cases 
of at least 30% with unknown causes, known as ‘idiopathic infertility’ [37]. 
 
In cattle, many defects and causes of infertility have been summarized [44, 45]. Chenoweth 
[46] has reviewed some genetic defects of sperm, which is the main reason for bull infertility. 
Furthermore, the pathogens that cause bull infertility or the pathogens that could be 
transmitted by bovine semen were reviewed by Givens and Marley [47]. 
 
1.2 Molecular biological research of male fertility in cattle 
1.2.1 Related QTL regions and genes  




the discovery of complex mechanisms of reduced male fertility. With the advancement of 
high-throughput technology and the availability of large amounts of data, genome-wide 
association study (GWAS), genome-wide scanning and other methods have been successfully 
applied for fertility estimation. Many regions and genes have been assumed to be indicators of 
bull fertility and the latest review summarized recent achievements [48]. 
 
Some molecular markers for testicular size, semen characteristics or sperm functions of bulls 
have been developed. A research of puberty in Brahman bulls illustrated that genomic regions 
on bovine chromosome 2 (BTA2), BTA14, and chromosome X are associated with hormone 
levels, scrotal circumference and normal sperm percentage [49]. Some GWAS have declared 
a number of single nucleotide polymorphism (SNP) markers, candidate genes and regions that 
are significantly associated with semen production traits, e.g., semen volume, number of 
sperms, motility and morphometry [50-53]. Feugang et al. [54] identified 97 markers that 
were significantly associated with fertility, in which integrin beta 5 (ITGB5) gene was 
confirmed to be involved in fertilization. The application of targeted sequencing of fertility-
related β-defensin genes and whole exome sequencing of AI bulls with varying fertility 
phenotypes has revealed many fertility-associated SNPs. The haplotype harboring several β-
defensin genes is highly correlated with the density of sperm binding to oviductal epithelial 
explants [55]. The SNP associations with noncompensatory fertility, which cannot be 
overcome by increasing the number of sperms, were estimated with 795 Holstein sires using a 
weighted Bayes B analysis, and 14 chromosomes regions showed different degree of signals. 
However, based on the low heritability of noncompensatory fertility, the accuracy of this 
prediction was low [56]. 
 
There are also some molecular markers associated with the fertility evaluation of field data 
phenotypes. A correlation analysis showed that FGF2 and STAT5A polymorphisms were 
associated with ERCR in a population of 222 Holstein bulls [57]. Peñagaricano et al. [58] 
conducted a GWAS and identified eight SNPs that were significantly associated with SCR. 
Some SNPs are located near or inside genes related to fertility, and some SNPs show marked 
dominant effects. Subsequently, an association analysis between highly conserved 
spermatogenesis genes from the fly to human and SCR was analyzed in an US Holstein 
population, and 5 significantly related SNPs located in three genes (MAP1B, PPP1R11, 
DDX4) were detected [59]. A comprehensive genomic study has illustrated eight genomic 




SCR as a parameter [60]. In these regions, many genes are associated with sperm physiology 
and male fertility. For example, CKB [61], TDRD9 [62], IGF1R [63], KAT8 [64] and CCT6A 
[65] are involved in sperm biology such as spermatogenesis, sperm capacitation and sperm-
oocyte interaction. A study revealed the non-additive effects on SCR of Holstein bulls. Four 
genomic regions on BTA8, BTA9, BTA13 and BTA17 exhibited dominance and/or recessive 
effects by using a two-step mixed model-based approach [66]. Most regions contain genes 
related to bull fertility, such as ADAM28 [67, 68], DNAJA1 [69], TBC1D20 [70], SPO11 [71], 
PIWIL3 [72] and TMEM119 [73], which play roles in testicular development, 
spermatogenesis and sperm maturation. In addition, a study on US Jersey dairy cattle 
identified ten regions on eight chromosomes that can account for more than 0.5% of the 
additive genetic variance for SCR. When non-additive effect was considered, two regions on 
BTA11 and BTA25 exhibited recessive effects. Most regions harbor genes with known 
functions of bull fertility [74]. A recent study detected eight runs of homozygosity (ROH) 
regions that were significantly associated with SCR, and the candidate genes involved in these 
regions were directly related to male fertility [75]. 
 
1.2.2 Epigenetic study  
In addition to the contribution of DNA, spermatozoa also provide RNAs, transcription factors 
and cell signaling molecules during the fertilization process [76]. For instance, Kropp et al. 
[77] tried to reveal the RNA expression and epigenetic characteristics of spermatozoa and 
embryos between bulls with different fertility status. 98 differentially expressed genes were 
detected in embryos which were generated by high or low fertility bulls, and 76 differentially 
methylated regions were found in the spermatozoa of these bulls. Lalancette et al. [78] 
demonstrated that sperms in high-NRR group displayed a higher proportion of transcripts in 
metabolism, signal transduction, translation, glycosylation, and protein degradation compared 
to low-NRR group. Arangasamy et al. [79] found an association between mRNA expression 
of CRISP2, CCT8 and PEBP1 in spermatozoa and different SCR scores in Holstein bulls. 
Card et al. [80] attempted to use RNA-sequencing to compare the oligo-dT selected sperm 
transcript profiles of bulls with varying fertility. Govindaraju et al. [81] have illustrated some 
differentially expressed miRNAs in the sperm from high and low fertility bulls and suggested 
that the miRNAs may play important roles in bull fertility. In addition, as more data are 
generated, DNA methylation information is being used as a biomarker of fertility in bulls. 




and low-fertility sires, identified 1765 differentially methylated cytosines and determined ten 
genes as candidate markers of bull fertility. 
 
A cohort of protein markers of fertility has also been identified using bulls with varying 
fertility. Peddinti et al. [83] detected 125 potential protein biomarkers that are differentially 
expressed in high and low fertility bull spermatozoa. D'Amours et al. [84] reported eight 
differentially expressed proteins in high and low fertility bulls, some of which are related to 
the proportion of live sperm. Furthermore, some sperm related proteins were detected, e.g., 
seminal plasma proteins [85], fertility-associated antigen [86] and the protein P25b on sperm 
[87], which can be used as potential indicators. 
 
1.2.3 Causative variants for bull sub- or infertility 
Although many biomarkers and genes related to bull fertility have been announced, only a 
few have been identified as causative mutations for cattle subfertility or infertility. A mutation 
in the 5’-upstream regulatory regions of FSHB can lead to decreased serum follicle-
stimulating hormone levels and further result in poor semen quality and low fertility in bulls 
[88, 89]. Another variant related to poor semen quality has been reported in Swedish Red 
cattle. A frameshift mutation in ARMC3 can cause the tail stump sperm defect [90]. A splice 
donor variant in CCDC189 can cause male sterility in the Nordic Red cattle by disrupting the 
movement of the sperm flagella [91]. One report of idiopathic male subfertility in Fleckvieh 
showed that a loss-of-function mutation in TMEM95 impacts the bull fertility but does not 
affect semen quality [92]. 
 
2 Overview of hemophilia B Leyden  
Hemophilia B is a recessive, X-linked bleeding disorder characterized by a deficiency of 
coagulation factor IX, caused by a different type of mutation in the F9 gene. Hemophilia B 
Leyden is a rare and unusual form of hemophilia B in which the causative mutations are all 
found in the F9 promoter sequence [93]. In 1970, this specific form of hemophilia B was 
reported in the Netherlands [94]. In hemophilia B Leyden patients, plasma FIX levels were 
less than 1% of normal during childhood, but gradually increased after puberty, reaching up to 
70% of normal [95]. In humans, mutations identified of hemophilia B Leyden in the F9 
promoter are concentrated in three regions: the first one is about 20 bp upstream of the major 
transcriptional start site (TSS, +1); the second one is at –5; and the third one is immediately 




binding sites of four transcription factors, namely androgen receptor (AR), hepatocyte nuclear 
factor 4α (HNF4α), one cut homeobox (ONECUT1/2) and CCAAT/enhancing-binding 
protein α (C/EBPα), respectively [93, 96-98]. These mutations alter the binding site and 
disrupt the interaction between the transcription factor and the recognition site, thereby 
affecting the expression of F9, at least before puberty. Compared to HNF4α, AR has been 
reported to have several alternative binding site motifs [99-101]. As androgen levels rise in 
childhood, transcript levels of F9 increase because the intact portion of the promoter is 
subsequently able to compensate for defective transcription factor binding sites [102, 103]. 
 
3 Gene function of Kruppel-like factor 7 (KLF7) 
Kruppel-like factors (KLFs) are important components of the transcriptional machinery of 
eukaryotic cells, regulating cell proliferation, differentiation and survival. They are 
characterized by inclusion of three C2H2 zinc fingers at the C-terminus that mediate binding to 
GC-rich sites. The amino acid sequence of the KLFs’ zinc finger region is highly conserved, 
but the regions beyond the zinc finger are often diverse. KLFs display a wide range of 
biological properties, each serving as an activator of transcription, a repressor, or both [104, 
105]. KLF7, also known as the ubiquitous kruppel-like factor (UKLF) due to its structure and 
ubiquitous expression pattern [106], has been reported to be involved in nervous system and 
adipogenesis. KLF7 has been shown to be involved in neuronal morphogenesis and 
neurogenesis [107, 108]. KLF7 is also thought to affect neurotransmission, which is an 
important component of the auditory system [109]. It has been reported that KLF7 expression 
can be influenced by the FBXO38 protein [110], and the interaction between FBXO38 and 
KLF7 is thought to be associated with the symptoms of hearing loss in human distal 
hereditary motor neuron disease [111]. KLF7 has been reported to be a candidate transcription 
factor of TCaRE3 (TRKB Ca2+ Response Element 3) [112]. TRKB-deficient mice model 
showed significant hearing loss and TRKB is involved in the remodeling of innervation in the 
mature cochlea, which means TRKB has potential in the treatment of hearing loss [113]. In 
addition, KLF7 has been reported to inhibit preadipocyte differentiation and promotes 
proliferation of preadipocyte in chickens [114]. One recent report revealed that KLF7 inhibits 
chicken adipogenesis through positive regulating of GATA3 expression in preadipocytes 
[115]. The two opposite directional results imply multiple roles for KLF7 in transcriptional 
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Abstract: We have identified a Holstein sire named Tarantino who had been approved for artificial
insemination that is based on normal semen characteristics (i.e., morphology, thermoresistance,
motility, sperm concentration), but had no progeny after 412 first inseminations, resulting in a
non-return rate (NRdev) of −29. Using whole genome association analysis and next generation
sequencing, an associated nonsense variant in the α/β-hydrolase domain-containing 16B gene
(ABHD16B) on bovine chromosome 13 was identified. The frequency of the mutant allele in the
German Holstein population was determined to be 0.0018 in 222,645 investigated cattle specimens.
The mutant allele was traced back to Whirlhill Kingpin (bornFeb. 13th, 1959) as potential founder.
The expression of ABHD16B was detected by Western blotting and immunohistochemistry in testis
and epididymis of control bulls. A lipidome comparison of the plasma membrane of fresh semen
from carriers and controls showed significant differences in the concentration of phosphatidylcholine
(PC), diacylglycerol (DAG), ceramide (Cer), sphingomyelin (SM), and phosphatidylcholine (-ether)
(PC O-), indicating that ABHD16B plays a role in lipid biosynthesis. The altered lipid contents may
explain the reduced fertilization ability of mutated sperms.
Keywords: Holstein cattle; male infertility; ABHD16B
1. Introduction
Fertility is an important economical productivity factor in animal breeding [1–4]. Indicators to
assess male fertility can either be indirect (e.g., productivity of progeny, sire conception rate, non-return
rate) or direct (e.g., semen characteristics, testis size) [5–10]. The latter parameters have the advantage
that they can be easily measured and they provide an immediate answer; however, the heritabilities of
scrotal circumference and semen traits vary extremely, ranging from 0.0 (i.e., abnormal heads, bent tails,
distal cytoplasmic droplets) to 0.57 (i.e., scrotal circumference) and, therefore, their use in selection
is not always straightforward [11]. Alternative approaches were used to determine the differences
Int. J. Mol. Sci. 2020, 21, 627; doi:10.3390/ijms21020627 www.mdpi.com/journal/ijms
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between fertile and infertile bulls while using molecular tools. Transcriptome analyses for instance
have shown that spermatozoa of high-fertility bulls show a higher concentration of specific transcripts
for membrane and extracellular space protein locations [12,13]. In another study residual RNA content
in spermatozoa of bulls with extreme non-return rates was analysed [14]. Low-fertile bulls showed a
significantly increased amount of ribosomal and mitochondrial sequences, whereas high-fertile bulls
exhibited transcripts of genes that are involved, for example, in metabolism, signal transduction,
translation, and protein degradation [14]. From transcriptome and proteome studies, mainly in man,
mouse, and rat, it is evident that differences between RNA and protein content, DNA methylation,
posttranslational modifications between fertile and infertile individuals exist [15–18]. The use of these
types of biomarkers in reproductive medicine is believed to bridge the gap between conventional
semen analysis with limited clinical utility and biochemical pathways that regulate male fertility [19].
However, the assessment of mutational effects in candidate genes is normally challenging,
especially when there are only subtle deviations in expression levels, due to the complex interactions
of geno- and phenotypes in fertility traits [20,21]. With the advancement of high-throughput screening
tools (DNA chip, next generation sequencing) and the availability of large datasets on fertility
parameters of bulls, especially in Holstein cattle male fertility, can be practically implemented into
genomic selection [22]. Genome-wide association studies have been conducted in Holstein bulls,
identifying several fertility associated genomic regions [23]. A recent genome-wide association study
has detected at least eight genomic regions, i.e., on bovine chromosome 5 (BTA5), BTA9, BTA13, BTA21,
and BTA25, in Holstein cattle associated with bull fertility while using Sire Conception Rate (SCR)
as a parameter [24]. In a large multi-species comparative study 33 promising candidate genes have
been identified for male fertility/infertility [25]. Recently, a whole exome sequencing of 24 high and
low fertile bulls identified 484 SNPs that were significantly associated with fertility [26]. The second
most significantly associated SNP in this study was located on BTA13 at position 53,691,419 within the
SIRPA gene. Although these data point at a number of potential molecular targets only three causative
mutations, resulting in male sub- or infertility in cattle have been determined in the FSHB, TMEM95,
and ARMC3 gene hitherto [27–30].
Here, we report about the identification of nonsense variant in the bovine α/β-hydrolase D16B
gene (ABHD16B) on BTA13 significantly associated with male subfertility in Holstein cattle. So far,
nothing was known regarding the physiological or biochemical function of ABHD16B [31,32]. Our data
provide evidence that ABHD16B is involved in lipid biosynthesis in testis and is crucial for fertilization.
2. Results
2.1. Conception Ability of Sires Is Highly Associated with a Chromosomal Region on Bovine Chromosome 13
A Genome Wide Association Analysis (GWAS) was performed while using a cohort of 289 Holstein
sires to determine chromosomal regions harboring associated causative genes for conception ability
(NRdev). The cohort consisted of 10 sires with a NRdev ≤ −2 (= cases) (Table 1) and 279 randomly chosen
sires of the active breeding population (= controls).
Individual NRdev values of the control sires were not available; however, they were assumed to be
normal, as all of these sires were used in the current breeding population. As shown in Figure 1A,
one genome-wide highly significant associated position on BTA13 (ARS-BFGL-NGS-107931; position
63,500,701) was detected (−log10P-value = 167.56). Seventeen additional regions above a Bonferroni
threshold of −log10P = 5.9 (p < 0.01) with much lower significance were present on BTA1, 2, 3, 6, 7, 8,
10, 11, 14, 17, 18, 21, 22, 24, 25, 26, and 27. The QQ-plot clearly indicated a compelling evidence for an
excess of association with no population substructure (Figure 1B). Whole-genome sequencing was
performed while using Tarantino and his parents to determine which of the associated chromosomal
regions harbored protein-altering variants that were causative for Tarantino’s infertility.
17
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Table 1. Sub- and infertile sires selected for genome-wide association analysis.











a) NRdev: Non-return rate deviation.
Figure 1. Manhattan plot of the Genome Wide Association Analysis (GWAS) (n = 289; 279 controls,
10 cases). (A) The plot shows the -log10-transformed p-values for all SNPs. The black horizontal line
represents the genome-wide significance threshold of −log10P = 5.9. (B) Quantile-quantile (QQ) plot of
the GWAS.
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2.2. Whole-Genome Sequencing Reveals Two Potential Protein-Altering Variants Upstream the Associated
Position on BTA13
Raw next generation sequencing data were quality filtered. Within the filtered 78,472 SNPs,
only 20 resulted in a predicted loss of function, including 10 nonsense variants, five splice-donor
variants, three splice acceptor-variants, and two initiator-codon variants. Two SNPs were located
near the associated position on BTA13, i.e., a nonsense variant at position 54,429,815 within the single
exonic α/β-hydrolase D16B (ABHD16B) gene (AC_000170.1: g.54429815G>A, rs468948776) and a
splice-acceptor variant at position 53,003,648 within the transmembrane channel-like protein 2 (TMC2)
gene (AC_000170.1: g.53003648C>T, rs465702794). TMC2 has been shown to be expressed in the
inner ear and it is necessary for the mechanotransduction in cochlear hair cells [33,34]. TMC2 was
excluded as potential candidate due to this very specific function. On the other hand, ABHD16B
has been shown in humans to be mainly expressed in testis, which suggested a potential role in
Tarantino´s infertility [35]. In addition, aberrant methylation patterns of ABHD16B have been shown
to be associated with infertility in men [36].
2.3. Verification and Validation of the Nonsense Variant g.54429815G>A (ABHD16B) in the Holstein Population
An initial set of 2072 randomly selected Holstein DNA samples were genotyped to verify
and validate the presence of the detected variant in ABHD16B. In this set, 2052 wild type (G_G),
20 heterozygous (G_A), and no homozygous (A_A) carrier were detected (HWE χ2= 0.05). The results
proved that the variant was present in the population at a very low frequency. Therefore, are
larger cohort of 222,645 HF cattle (208,165 female, 14,480 male) was genotyped while using the
bovinSNP50 BeadChip. In this cohort, 810 heterozygous (781 female, 19 male, 10 unknown sex) and no
homozygous animals were identified, resulting in a frequency of the variant allele of 0.0018. According
to Hardy—Weinberg equilibrium it was not unexpected that no homozygous individuals were detected
(HWE χ2= 0.73). The low allele frequency further supported the data that the nonsense variant in
ABHD16B was most likely the causative variant for Tarantino´s infertility, because sires will be rapidly
removed from the breeding population once a sub- or infertility would have been evident during
routine fertility testing. Such a selection will efficiently reduce the transmission and spreading of the
causative variant. The limited number of heterozygous individuals in the randomly chosen large
Holstein cohort prompted us to determine the number of heterozygous sires in the available DNA
samples of Tarantino´s close male relatives in correlation with their conception ability (NRdev). A total
of 34 DNA samples were available and genotyped, resulting in 16 wild type and 18 heterozygous sires
(HWE χ2= 4.4). Within the heterozygous sires, 15 had negative NRdev values (−9 to < 0) and only three
sires showed positive NRdev values (0 to 2).
2.4. Expression and Tissue Distribution of ABHD16B
ABHD16B codes for a protein of 470 amino acids with a predicted α/β-hydrolase fold domain.
The nonsense variant g.54429815G>A causes a premature stop at amino acid position 218 (glutamine
residue), resulting in a truncation of 253 C-terminal amino acids and 53.8% of the protein (Figure 2).
In silico protein sequence comparison of 11 mammals revealed that the glutamine residue (Q) is highly
conserved. Due to the truncation 67.4% of the α/β-hydrolase fold domain is missing. Regarding the
evolutionary appearance, it is interesting to note that ABHD16B first evolved in reptiles performing
internal fertilization. Species with external fertilization, e.g., fish and frogs, do not harbor an
ABHD16B gene.
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Figure 2. (A) Schematic representation of the ABHD16B protein structure indicates the position of the
α/β-hydrolase fold domain (blue) and the transmembrane helices (green), predicted by NCBI Conserved
Domains Database and TMbase, respectively. The amino acid position (218) of the nonsense variant
leading in a premature stop is marked by a red triangle. (B) The comparative alignment of amino acid
sequences of 11 mammals while using Clustal W (178-amino acid position 178–237) is shown. The amino
acid position at the truncation site is indicated in red. NCBI protein sequence accession numbers
are as follows: Bos (Bos Taurus) NP_001033630.1, Ovis (Ovis aries) XP_014955258.1, Felis (Felis catus)
XP_003983341.3, Sus (Sus scrofa) XP_020933693.1, Pan (Pan troglodytes) XP_003317106.1, Homo (Homo
sapiens) NP_542189.1, Macaca (Macaca mulatta) NP_001180656.1, Oryctolagus (Oryctolagus cuniculus)
XP_008250767.2, Mus (Mus musculus) NP_899004.1, Loxodonta (Loxodonta Africana) XP_003421827.1,
Tursiops (Tursiops truncates) XP_019806804.1. (C) The amino acid sequence of bovine ABHD16B
truncated protein with the stop-gain variant.
2.5. ABHD16B Is Expressed in Testis but not in Spermatozoa
Western blotting was used to detect ABHD16B in testis (wild type) and spermatozoa (wild type,
heterozygous, and homozygous variant) extracts. Testes of heterozygous and/or homozygous carriers
were unavailable due to the low genotype frequencies. However, a limited amount of deep-frozen
semen samples of Tarantino and a further not directly related homozygous carrier (Ca) provided from
the safety inventory of an AI station were included in the analysis. An ABHD16B specific band was
detected in testis of wild type bulls at the expected size of approx. 70 kDa, as shown in Figure 3.
Neither in wild type nor in heterozygous or homozygous variant spermatozoa extracts ABHD16B was
detected (Figure 3B).
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Figure 3. Western blot analysis of ABHD16B protein expression in tissues and spermatozoa. (A) ABHD16B
protein band (red arrow) detected in wild type testis (G_G) but not in spermatozoa. Using liver as
negative control, muscle and human ABHD16B over-expression lysate as positive controls (PC).
α-Tubulin used as the loading control. (B) ABHD16B (approx. 70 kDa) is absent in spermatozoa of
three genotypes (wild type (G_G), heterozygous (G_A) and homozygous carrier (A_A)). Spermatozoa
of homozygous carriers were from Tarantino and Ca. (C) Box and Whisker plot of relative ABHD16B
expression. Areas under curve were determined using ImageJ 1.52k software and relative expression
ratios of ABHD16B (%) in liver, muscle, testis, and spermatozoa (G_G) were calculated while using
α-Tubulin expression as internal standard. Horizontal lines within boxes indicate median values and
whiskers show upper and lower extremes.
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2.6. Immunohistochemical Analysis Revealed ABHD16B Expression in Testis and Epididymis
Sections of testicular and epididymal tissue samples that were collected at an abattoir were
prepared for IHC. The ABHD16B genotype of the samples was tested prior to IHC and shown to
originate from wild type sires. While using the PAC-ARK antibody, ABHD16B expression was
detectable in testicular parenchyma, ductuli efferentes, as well as epididymal tail, body, and head, as
shown in Figure 4. Specifically, there is ABHD16B expression in the nucleoplasm of Leydig cells, in the
seminiferous tubules and, with variable intensity, in the epithelium of the ductus epididymis. These
findings suggest that ABHD16B probably plays a role in spermatogenesis and sperm maturation.
Figure 4. ABHD16B protein detection and localization in testis and epididymis of wild type bull
by immunohistochemistry. PAC-ARK antibody was used as primary antibody. Positive staining is
indicated with red arrows. When the primary antibody (PAC-ARK) was replaced with antibody diluent
and isotype rabbit IgG at the same working dilution, no staining was observed in any of these tissues.
Scale bars = 50 µm.
2.7. ABHD16B Is Involved in Lipid Metabolism and Influences Sperm Plasma Membrane Lipid Composition
We hypothesized that ABHD16B could be involved in plasma membrane lipid biosynthesis,
as many members of the α/β-hydrolase superfamily of hydrolytic enzymes are involved in lipid
metabolism. Sperm lipidomics of heterozygous and wild type semen samples was performed to
interrogate this hypothesis. The number of available semen samples of Tarantino was limited and,
therefore, it was decided not to include these valuable samples. However, if ABHD16B would have an
effect on lipid biosynthesis during spermatogenesis, this should also be detectable in heterozygous
samples. After normalization to 106 sperms per sample, no significant difference in the total lipid
content between 15 wild type and 15 heterozygous samples was detected (Figure 5).
Figure 5. Total lipid amount of 106 sperms of each genotype revealed no significant difference after
normalization. G_G: wild type; G_A: heterozygous carrier.
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However, 10 out of 16 lipid classes showed significant differences (Figure 6A). The majority of
different lipids belonged to the classes of diacylglycerols (DAG), glycerophosphocholines (PC, PC O-),
ceramides (Cer), and sphingomyelins (SM). The sperms of heterozygous carriers showed significantly
decreased amounts of SM and DAG, while PC, PC O-, and Cer were increased (Figure 6A). In total,
99 of 144 lipid species demonstrated significant differences between wild type and heterozygous sperm
samples. Eight lipid species significantly decreased (p(BH)<0.05, log2fc < −1), six of them were DAGs.
25 lipid species significantly increased (p(BH) < 0.05, log2fc > 1), almost half (n=12) of them were PCs
(Figure 6B). Figure 6C shows the ten most significantly changed lipid species. An important indicator
of cell membrane integrity is the PC:PE ratio. As shown in Figure 6D, heterozygous sperms have
a significantly increased the PC:PE ratio. Another sperm membrane structure criterion is the ratio
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Figure 6. Lipid distribution and variance of spermatozoa in wild type and heterozygous sires.
(A) Change profile of total lipid content for each lipid class of sperms in two genotypes. (B) −log10 of
adjusted p-value (p(BH)) and mean log2-fold change (G_A vs G_G) of 144 lipid species were plotted,
lipid species with −log10p(BH) >1.3 and |log2fold change|>1 (dashed grey lines are included) were
annotated with lipid feature names (simplified without the saturated acyl groups). (C) Top 10 most
significantly changed lipid species between G_G and G_A bull sperm cells. (D) Bar chart shows the
mean of PC:PE ratio in G_G and G_A bull sperms. (E) Bar chart shows the ratio between LPC 22:6 and
PC 16:0_22:6 in two genotypes. G_G: wild type; G_A: heterozygous. Differential changes were tested
by the Mann–Whitney U test or Student’s t-test. Data are presented as mean ± SEM; n = 15/group; FDR
adjusted p-values are indicated: * p < 0.05, ** p < 0.01, *** p < 0.001.
3. Discussion
Male infertility is a complex multifactorial idiopathic, congenital, or acquired heterogeneous
disease [37,38]. In men, genetic factors predominantly cause idiopathic conditions contributing to
30–40% of male infertility [39]. However, up to now, for only three genes, i.e., NR5A1, DMRT1, and
TEX11, associations with male infertility have been evidenced in independent biological and functional
studies [40]. The same number of genes has been identified in cattle causing bull sub- or infertility so
far, i.e., FSHB (BTA15, 61.7 Mb), TMEM95 (BTA19, 27.6 Mb), and ARMC3 (BTA13, 24.3 Mb) [27–30].
Although the exact chromosomal positions of these genes differ from precise infertility associated
chromosomal regions that have been identified either by QTL studies, GWAS using SCR as parameter, or
whole exome sequencing, they are located on the same chromosomes [24,26,41]. Regarding the location
of ABHD16B on BTA13, it is noteworthy that not only ARMC3 is located on the same chromosome,
but also QTLs for percentage of normal sperms (68.18 cM), male fertility (43.76 cM), and non-return
rate (EBV) (85.19 cM) have been mapped to BTA13 [42–44]. One region explaining roughly 0.6% of
the genetic variance of SCR was detected on BTA13 from position 58,456,868–59,951,247 harboring
two potential candidate genes for male fertility, i.e., CTCFL and SPO11 [45]. This region is located
approximately 4 Mb downstream of ABHD16B. The closest SNP identified by whole exome sequencing
was located on BTA13 at position 53,691,419 within the SIRPA gene only 738,396 bp upstream of the
nonsense variant in ABHD16B. In a further GWAS using a much larger dataset (11.5 k Holstein bulls)
and higher density SNP chip (about 300 k), five markers with marked dominance effects were detected,
one of them being located on BTA13 (13:g.60263194A>C; rs41701032) [46]. Hence, the molecular genetic
data that are published elsewhere are well in agreement with our findings.
The identification of ABHD16B as an associated causative gene for bull infertility also allowed for
us to elucidate its biochemical function. Except that ABHD16B belongs to a large protein superfamily
of catalytic enzymes harboring an α/β-hydrolase domain and is predominantly expressed in Leydig
cells of the testis, nothing was known regarding its biochemical or physiological function so far [31].
The methylation of ABHD16B was reported to be associated with chronic obstructive pulmonary
disease (COPD) and aberrant methylation patterns were identified in infertile man [32,36]. In proteome
studies, 11 members of the ABHD family (1, 2, 5, 6, 10, 11, 12, 13, 14B, 16A, 17A, 17B) have been
detected in testis or spermatozoa [47,48]. Human ABHD2 participates in sperm hyperactivation as a
lipid hydrolase through depleting endocannabinoid 2-arachidonoylglycerol (2-AG), an inhibitor of
sperm calcium channel (CatSper) [49]. However, in most cases, their exact role remains elusive.
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Our data show that ABHD16B is involved in lipid biosynthesis of DAGs. According to the
ABHD16B molecular structure, it is supposed to participate in lipid metabolism, like other ABHD
family members, which could contribute to sperm maturation. Sperm lipidomics of two different
genotypes was performed to confirm this. Sperm lipid composition changes during their maturation
through the epididymis, the percentage of SM in spermatozoa increased [50,51]. SM is synthesized
by the combination of Cer and phosphorylcholine from PC. During this reaction, DAG is produced
as a by-product [52]. Our data demonstrated that SM and DAG were significantly decreased, while
PC and Cer were significantly increased in heterozygous spermatozoa. This implies that ABHD16B
might be involved in the lipid biosynthesis of DAG, which influences SM synthesis in the later process.
On the other hand, increased levels of PCs in heterozygous sperms could also result from an inhibited
degradation from PC to DAG and phosphorylcholine. Cer increased correspondingly without enough
phosphorylcholine combined to synthesize SM.
The presence of ABHD16B in the epididymis, as shown by IHC, suggests a role in the lipid
metabolism of DAG and SM during sperm maturation. DAG also influences the synthesis of 2-AG,
which is an inhibitor of sperm calcium channel (CatSper) preventing sperm hyperactivation. DAG is
hydrolized to 2-AG by diacylglycerol lipase (DAGL) and, hence, decreased DAG levels in homozygous
carrier sperms could result in an insufficient amount of 2-AG leading to a premature capacitation [53].
Furthermore, this effect could be enhanced by the lack of SM. On the other hand, the accumulation of
PC and Cer could also interfere with the fertilization capacity. For instance, increased PC concentrations
in chicken sperms were reported to be negatively associated with fertility during aging [54]. It has also
been observed that imbalanced lipid homeostasis of PC and SM caused sperm membrane instability
and infertility in knockout mice [55]. The final sperm lipid composition is formed during epididymal
maturation, which results in a decreased amount of cholesterol, PS, CL, PE, and PI, and an increase
in PC and DAG. The amount of PI, PC, and DAG was significantly different between the wild
type and heterozygous variant spermatozoa (Figure 6A), indicating a potential role of ABHD16B in
sperm maturation.
Another impact of ABHD16B on lipid metabolism can be seen in the increased PC:PE ratio.
Abnormal PC:PE ratios affect membrane permeability, fluidity, and integrity [56,57]. In cells that
have abundant unsaturated fatty acids, such as spermatozoa, LPC is normally regarded as a marker
of sperm membrane quality and oxidative stress. The increase of LPC content in the deteriorated
membrane of spermatozoa indicates affected acrosome reaction, and an increased ratio between LPC
22:6 and PC 16:0/22:6 was observed in human spermatozoa with impaired membrane [58]. The ratio
was also significantly enhanced in the heterozygous samples analysed here. Furthermore, LPC 22:6 is
a reliable marker of spermatozoa lipid oxidation [59]. A significant increased concentration of LPC
22:6 was also found in heterozygous carrier samples. This could result in a higher oxidized state or
membrane damaged level in contrast to wild type sperms. The lipidomics analysis clearly showed that
the loss of ABHD16B function has a profound effect on sperm plasma membrane lipid composition.
Therefore, in analogy with experiments in humans and mice, it can be hypothesized that the altered
lipid composition of the ABHD16B homozygous carrier sperms interferes with the fertilization ability.
4. Materials and Methods
4.1. Ethical Statement
EDTA blood samples of cattle were taken for routine parentage control exclusively by local
veterinarians. The Lower Saxony State Office for Consumer Protection and Food Safety approved the
collection of samples (33.19-42502-05-17A196), according to §8a Abs. 1 Nr. 2 of the German Animal
Protection Law.
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4.2. Genome Wide Association Analysis (GWAS)
The conception ability of sires (non-return rate, NRdev) was calculated based on the latest
three daughter proven service-sire age groups (2019: A.I. sires born 2014–2016; 0% deviation).
The NRdev is expressed in %-deviation on the original non-return-rate scale. Sires in the breeding
population with NRdev values of approx. ± 2% are scored as average (for more information see
https://www.vit.de/fileadmin/DE/Zuchtwertschaetzung/Zws_Bes_eng.pdf). Data of NRdev deviations
of service-sires were provided by VIT (https://www.vit.de/en/).
For GWAS 279 sires of the current breeding population were randomly chosen as presumably
fertile controls. As cases 10 sires (including Tarantino, NRdev = −29) with NRdev between −29 and
−2 were selected (Table 1). The 289 samples were genotyped while using the Illumina BovineSNP50 or
MD BeadChip. The chips were processed on a HiScan SQ and iScan System (Illumina GmbH, Munich,
Germany) and raw data were converted using GenomeStudio Software (Illumina GmbH, Munich,
Germany). Final reports were imported into SVS 8.8.3 for MacOSX (Golden Helix Inc. Bozeman, MT,
USA). Prior to GWAS data were filtered while using a call rate <0.95, number of alleles >2, minor
allele frequency (MAF) <0.05, and Fisher´s HWE <0.001 (based on controls) as marker dropping
criteria. LD pruning was performed with a window size of 100 and increments of 5. R2-LD statistics
with a threshold of 0.5 while using Cochran-Mantel-Haenszel (CHM) as computation method was
applied. After filtering, 38,671 markers remained for further analysis. GWAS was done using a
multi-locus mixed model (MLMM) while applying an additive genetic model with correction for male
X-chromosomal hemizygosity [60,61]. The associations were regarded as statistically significant above
a Bonferroni threshold of −log10P = 5.9 (p = 0.01). The associations of markers (−log10P-value, y-axis)
were plotted against their chromosomal positions (UMD3.1.1, x-axis).
4.3. Next Generation Sequencing of Tarantino and Its Parents
Tarantino and its parents were sequenced on a HiSeq2500 System (Illumina GmbH, Munich,
Germany), resulting in approx. 109 total reads per sample. Low quality (average phred quality < 15)
and single reads were removed, resulting in approx. 9.4 × 108 per sample. Mapping to the bovine
reference genome sequence (UMD3.1.1) was done while using BWA [62]. PCR duplicates were removed
using Picard (http://broadinstitute.github.io/picard/). After read mapping, alignment and refinement
approx. 7.8 × 108 reads remained per sample, corresponding to an average depth of coverage of approx.
46x (mean insert size 360 bp). A total of 9,315,126 SNPs and 1,439,972 indels were called using GATK
Haplotype Caller [63]. SNP & Variation Suite 8.8.3 (Golden Helix Inc., Bozeman, MT, USA) was used
for further analysis. SNPs and indels were set to missing with read depth ≤ 10, genotype quality ≤ 15,
alt read ratios for Ref_Ref ≥ 0.15, Ref_Alt outside 0.3 and 0.7, Alt_Alt ≤ 0.85, and according to their
inheritance pattern (Tarantino = Alt_Alt, parents Alt_Ref). After this filtering, 307,898 SNPs and 604
indels remained. A final filtering was done while using SNPs and indels only in annotated and verified
mRNA transcripts, including splice donor and acceptor distances of 2 bp, splice region exonic distances
of 3 bp and splice region intronic distances of 8 bp, resulting in 78,472 SNPs and 125 indels.
4.4. Genotyping of SNP rs468948776 (ABHD16B)
The nonsense variant in ABHD16B was genotyped while using fluorescence resonance energy
transfer (FRET) analysis on a LightCycler 480 (Roche Life Science, Mannheim, Germany). The DNA
concentrations were measured using NanoDrop ND-1000 spectrophotometer (PEQLAB Biotechnologie
GmbH, Erlangen, Germany). Conventional PCR primers were designed using the online program
Primer3 (http://bioinfo.ut.ee/primer3-0.4.0/). The FRET primers were designed with MeltCalc
Software [64,65]. Table 2 lists FRET primers and probes.
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Table 2. Fluorescence resonance energy transfer (FRET) primers and probes used for genotyping of
ABHD16B variant.
Gene Primer Name Sequence (5’->3’) Probe Name Sequence (5’->3’)
ABHD16B
ABHD16B_FRET_f ACCCGGGCTTCGGGGGCAGC ABHD16B_FRET_Pro [Cy5]CGTTCCCTCAGCATGATG[Phos]
ABHD16B_FRET_r GCGTACTTGACCACCACGTC ABHD16B_FRET_Anc GGGGCAGCACGGGCG[Flc]
SNP rs468948776 (ABHD16B) was amplified in a total volume of 25 µL, including 20 ng DNA,
10 µmol forward and reverse primer each, 10 µmol probe and anchor (Sigma-Aldrich, Taufkirchen,
Germany) each, 1 × GC-RICH solution, 1 × PCR reaction buffer (including 20 mM MgCl2), 100 µmol
dNTPs and FastStart Taq Polymerase (1U; Qiagen, Hilden Germany) for 34 cycles at 95 ◦C for 15 S,
60 ◦C for 20 S, and 72 ◦C for 20 S. The melting curves were done using the following program: 95 ◦C
for 30 S, 37 ◦C for 30 S, 95 ◦C continuous acquisition mode (2/◦C), ramp rate 0.29 ◦C/S, followed by
37 ◦C for 30 S.
4.5. Western Blotting
Immunoblotting on cryopreserved semen specimens of one wild type (G_G), one heterozygous
carrier (G_A), two homozygous affected (A_A; Tarantino, Ca), and testis, muscle, and liver samples of
wild type bulls were prepared. The semen samples of sire Ca were provided from the safety-inventory
of a AI station. Human ABHD16B over-expression lysate (NM_080622, OriGene, Rockville, MD, USA)
was used as a positive control. Frozen semen samples were thawed at 37 ◦C in a water bath for 30 S.,
followed by 3 × washes with phosphate-buffered saline (PBS; Invitrogen/ThermoFisher Scientific)
and lysed in cold RIPA buffer (Sigma, R0278, St. Louis, MO, USA). Protease inhibitor (Roche, Cat.
No.04693159001, Mannheim, Germany) and phosphatase inhibitor (Roche, Cat. No. 04906845001,
Germany) were added to RIPA buffer in advance. The samples were incubated for 1 h at 4 ◦C and
centrifuged at 16,000× g for 20 min. at 4 ◦C. An additional homogenization of tissue samples with
MagNA lyser green beads (Roche Life Science, Mannheim, Product No. 03358941001, Germany) was
carried out followed by an incubation for 2 h at 4 ◦C and then centrifuged at 16,000× g for 20 min.
at 4 ◦C. Protein quantification was performed by Bradford method with the dye reagent concentrate
(Bio-Rad, Cat. No. 5000006, Munich, Germany).
After denaturation (10 min. at 70 ◦C) in LDS sample buffer with 5% 2-mercaptoethanol, equal amounts
of protein were loaded to SDS-PAGE (8% Bis-Tris Plus gel, ThermoFisher Scientific, Cat. No. NW00087BOX,
USA). After electrophoresis at 15V for 1h, the proteins were transferred onto nitrocellulose membranes
(Sigma, Cat. No. 10600098, Germany) with semi-dry blotter (Brenzel Bioanalytik, Lahntal, Germany).
Membranes were blocked with 5% non-fat dry milk in TBS-T (0.1% Tween) overnight at 4 ◦C and
then incubated with primary antibodies for 1 h at room temperature, followed by incubation with
the secondary antibodies at room temperature for 1 h. Subsequently, the membranes were incubated
with an ECL detection reagent (GE Healthcare, Product No. RPN2109, Little Chalfont, UK) and then
exposed to X-ray films (GE Healthcare, Product No. 28906836, Tokyo, Japan) for detection.
A customized bovine ABHD16B primary antibody, affinity purification PAC-DFR (Davids
Biotechnologie GmbH, Regensburg, Germany, 1 µg/mL dilution) was used. Goat Anti-Mouse IgG
(H + L)-HRP (Bio-Rad, Munich, Germany; 1:10,000 dilution) and Goat Anti-Rabbit IgG (H + L)-HRP
(Bio-Rad, Germany; 1:10,000 dilution) were the secondary antibodies. Anti-α-Tubulin (Sigma, T9026;
1: 2500 dilution) was used as the loading control.
The quantification of ABHD16B Western blots was done using ImageJ 1.52k software [66]. Areas
under curve of ABHD16B specific bands were determined for liver, muscle, testis and spermatozoa
(G_G). Relative expression ratios (%) were calculated with α-tubulin as the internal standard and
plotted as Box and Whisker plot.
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4.6. Immunohistochemistry of Testes
Testicular and epididymal tissues were obtained from freshly slaughtered wild type Holstein
cattle and they were immediately fixed in 4 % formaldehyde for 48 h. Immunohistochemistry
(IHC) was performed on paraffin-embedded sections, including testicular parenchyma, as well
as ductuli efferentes, epididymal head, corpus, and tail with efferent ducts and epididymal duct,
respectively. The primary polyclonal antibody was directed against the PAC-ARK peptide and
it was generated in the rabbit according to standard protocols (Davids Biotechnologie GmbH,
Regensburg, Germany). IHC was performed in an automated immunostaining system (Discovery
XT, Roche Diagnostics GmbH, Mannheim, Germany) at a dilution of 1:1000 while using the SABC
(streptavidin-biotin-complex) method, mild EDTA (ethylenediaminetetraacetic acid) pretreatment,
and DAB (diaminobenzidine tetrahydrochloride) for signal detection (DAB Map Kit, Roche Diagnostics
GmbH, Mannheim, Germany). A rabbit IgG isotype control (ABIN3023746, antibodies-online GmbH,
Aachen, Germany) was included at the same concentration as the primary antibody for confirmation
of primary antibody specificity. Additionally, pure antibody diluent instead of primary antibody was
applied to the control sections for an evaluation of non-specific binding of the secondary antibody.
4.7. Lipidomics of Wild Type and Heterozygous Spermatozoa
4.7.1. Semen Collection for Lipidome Analysis
Wild type and heterozygous fresh semen samples were prepared for lipidome analysis. Three
independent fresh ejaculates were collected from a heterozygous bull and five technical replicates
were produced by dilution from each sample. Wild type semen samples were flushed from the
epididymal tail of four unrelated bulls and a total of 15 technical replicates were generated by
dilution. In the epididymal tail, spermatozoa are matured and the lipid composition is equivalent to
ejaculated spermatozoa [67,68]. The samples were washed twice in Dulbecco’s phosphate-buffered
saline (D-PBS) without magnesium and calcium and centrifugated at 1000× g for 5 min. at 4 ◦C. The
cells were resuspended in D-PBS to a final concentration of approximately three million–eight million
cells/mL. Cell density was determined in an improved Neubauer counting chamber (Marienfeld GmbH,
Lauda-Königshofen, Germany).
4.7.2. Lipid Extraction for Mass Spectrometry Lipidomics
Mass spectrometry-based lipid analysis was performed by Lipotype GmbH (Dresden, Germany), as
described [69]. The lipids were extracted while using a two-step chloroform/methanol procedure [70].
The samples were spiked with internal lipid standard mixture containing: cardiolipin 16:1/15:0/15:0/15:0
(CL), ceramide 18:1;2/17:0 (Cer), diacylglycerol 17:0/17:0 (DAG), hexosylceramide 18:1;2/12:0
(HexCer), lyso-phosphatidate 17:0 (LPA), lyso-phosphatidylcholine 12:0 (LPC), lyso-phosphatidylethano-
lamine 17:1 (LPE), lyso-phosphatidylglycerol 17:1 (LPG), lyso-phosphatidylinositol 17:1 (LPI),
lyso-phosphatidylserine 17:1 (LPS), phosphatidate 17:0/17:0 (PA), phosphatidylcholine 17:0/17:0 (PC),
phosphatidylethanolamine 17:0/17:0 (PE), phosphatidylglycerol 17:0/17:0 (PG), phosphatidylinositol
16:0/16:0 (PI), phosphatidylserine 17:0/17:0 (PS), cholesterol ester 20:0 (CE), sphingomyelin 18:1;2/12:0;0
(SM), and triacylglycerol 17:0/17:0/17:0 (TAG). After extraction, the organic phase was transferred to
an infusion plate and dried in a speed vacuum concentrator. First step dry extract was re-suspended
in 7.5 mM ammonium acetate in chloroform/methanol/propanol (1:2:4, V:V:V) and second step dry
extract in 33% ethanol solution of methylamine in chloroform/methanol (0.003:5:1; V:V:V). All liquid
handling steps were performed while using Hamilton Robotics STARlet robotic platform with the Anti
Droplet Control feature for organic solvents pipetting.
4.7.3. MS Data Acquisition
The samples were analyzed by direct infusion on a QExactive mass spectrometer (Thermo
Scientific, Osterode am Harz, Germany) equipped with a TriVersa NanoMate ion source (Advion
28
Int. J. Mol. Sci. 2020, 21, 627 14 of 18
Biosciences, Ithaca, NY, USA). Samples were analyzed in both positive and negative ion modes with
a resolution of Rm/z=200=280000 for MS and Rm/z=200=17500 for MSMS experiments, in a single
acquisition. MSMS was triggered by an inclusion list that encompasses corresponding MS mass ranges
scanned in 1 Da increments [71]. MS and MSMS data were both combined to monitor CE, DAG, and
TAG ions as ammonium adducts; PC, PC O-, as acetate adducts; and, CL, PA, PE, PE O-, PG, PI, and PS
as deprotonated anions. MS only was used to monitor LPA, LPE, LPE O-, LPI, and LPS as deprotonated
anions; Cer, HexCer, SM, LPC, and LPC O- as acetate adducts.
4.7.4. Data Analysis and Post-Processing
The data were analyzed with in-house developed lipid identification software based on
LipidXplorer [72,73]. Data post-processing and normalization were performed while using an
in-house developed data management system. Only lipid identifications with a signal-to-noise ratio
>5, and a signal intensity five-fold higher than in corresponding blank samples were considered for
further data analysis.
The total lipid amount occurring in each sperm sample were pre-tested to ensure that optimal
amounts are used to achieve the greatest analysis quality and result comparability, despite the broad
dynamic range of our analytical methods. Afterwards, the initially detected total lipid amount per
sample was normalized to one-million sperms. A significant difference between normalized total lipid
amount of wild type and heterozygous samples was analyzed.
A 70% occupational threshold was applied for data filter, valid data in more than 10 samples for
each genotype were selected, NAs were replaced with zeros. Afterwards, lipid data that were present
in both genotypes were chosen for further analysis. In total, 16 lipid classes with 144 lipid species were
evaluated, and the data were analyzed in terms of lipid class and species separately. Shapiro–Wilk
Test was used for normal distribution detection [74]. Significant difference analysis was performed
with Mann–Whitney U-test or two-tailed t-test, depending on the normal distribution results by
SPSS 16.0. PC:PE and (LPC 22:6):(PC 16:0_22:6) ratios were also checked for significant difference.
Benjamini & Hochberg method was used for p-value adjustment of multiple testing [75] with R version
3.5.1, p(BH) < 0.05 were considered to be statistically significant (Table S1). The comparison results
of lipid classes and 10 most significantly changed lipid species between wild-type and rs468948776
heterozygous samples were demonstrated in histograms (data are presented with mean ± standard
error of mean). 144 lipid species were plotted with Y-axis of adjusted values (−log10pBH) against
X-axis of log2fold change (heterozygous vs wild type).
5. Conclusions
We have identified a nonsense mutation in the bovine ABHD16B gene as a potential causative
protein-altering variant for male infertility in Holstein cattle. This made it possible to elucidate the so
far unknown physiological and biochemical role of ABHD16B in lipid biosynthesis, spermatogenesis,
and fertilization. Our findings could also have implications on further elucidating a novel genetic
cause for human male infertility, due to the fact that a number of deleterious variants, e.g., missense,
frameshift, indels and one stop-gain variant in the human ABHD16B gene have been reported to the
human ENSEMBL database.
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Hemophilia B is a classical monogenic, X-chromosomal, recessivelytransmitted bleeding disorder caused by genetic variants within thecoagulation factor IX gene (F9). Although hemophilia B has been
described in dogs, it has not yet been reported in the Hovawart breed. Here
we describe the identification of a Hovawart family transmitting typical
signs of an X-linked bleeding disorder. Five males were reported to suffer
from recurrent hemorrhagic episodes. A blood sample from one of these
males with only 2% of the normal concentration of plasma factor IX
together with samples from seven relatives were provided. Next-generation
sequencing of the mother and grandmother revealed a single nucleotide
deletion in the F9 promoter. Genotyping of the deletion in 1,298 dog spec-
imens including 720 Hovawarts revealed that the mutant allele was only
present in the aforementioned Hovawart family. The deletion is located 73
bp upstream of the F9 start codon in the conserved overlapping DNA bind-
ing sites of hepatocyte nuclear factor 4α (HNF-4α) and androgen receptor
(AR). The deletion only abolished binding of HNF-4α, while AR binding
was unaffected as demonstrated by electrophoretic mobility shift assay
using human HNF-4α and AR with double-stranded DNA probes encom-
passing the mutant promoter region. Luciferase reporter assays using wild-
type and mutated promoter fragment constructs transfected into Hep G2
cells showed a significant reduction in expression from the mutant promot-
er. The data provide evidence that the deletion in the Hovawart family
caused a rare type of hemophilia B resembling human hemophilia B
Leyden.
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ABSTRACT
Introduction
Hemophilia B (Christmas disease) is a recessive, X-linked bleeding disorder
caused by genetic variants within the clotting factor IX gene (F9) resulting in the
absence or insufficient levels of factor IX (FIX) in the blood.1 In humans hemophilia
B is also known as the “royal disease” as it was transmitted into several European
royal dynasties by Queen Victoria.2,3 As of present, 1,113 unique F9 variants have
been described in humans.4 The majority of the pathogenic variants are located
within exons (n=923) and intronic regions (n=137) of F9. Only 33 variants (2.96%)
have been described in the 5’-UTR (n=28) and 3’-UTR (n=5) accounting for 2.52%
and 0.45% of human pathogenic hemophilia B variants, respectively.4
Although the first reports about canine hemophilia B date back to the early 1960s
35
and this was the first disorder in dogs characterized on the
DNA level, data on hemophilia B cases in dogs remain
rather scarce compared to data from humans.5-8 For
instance, in the Cairn Terrier colony of the Francis Owen
Blood Research Laboratory (University of North Carolina,
Chapel Hill, NC, USA) a G>A transition
(NC_006621.3:g.109,532,018G>A) in exon 8 causing an
amino acid exchange (NP_001003323.1:p.Gly418Glu) that
resulted in a complete lack of circulating FIX was detected
in affected dogs.9 Due to a complete deletion of F9 in a
Labrador Retriever, FIX inhibitors were produced after
transfusion of canine blood products.10 In a study of Pit
Bull Terrier mixed breed dogs and Airedale Terrier dogs a
large deletion of the entire 5’ region of F9 extending to
exon 6 was found in the former and a 5 kb insertion dis-
rupting exon 8 was described in the latter.11 As in the
Labrador Retriever with hemophilia B, FIX inhibitors were
produced in both breeds. A mild form of hemophilia B in
German Wirehaired Pointers was caused by a 1.5 kb Line-
1 insertion in intron 5 of F9 at position
NC_006621.3:g.109,521,130.12 Until today, hemophilia B
has been described in four mixed-breed dogs and nine dog
breeds, i.e. German Shepherd, Lhasa Apso, Labrador
Retriever, Rhodesian Ridgeback, Airedale Terrier, Cairn
Terrier, Maltese, Mongrel and German Wirehaired
Pointer.9-17
In the canine cases analyzed so far on the DNA level,
mutations have been observed only in exons and introns
of F9, whereas alterations of the F9 promoter have not
yet been reported. In humans promoter variants have
been detected and result in the so-called hemophilia B
Leyden characterized by low levels of FIX until puberty,
whereas after puberty FIX concentrations rise to almost
normal levels.18-20 Since its first description, the genetic
background of human hemophilia B Leyden was elucidat-
ed by various studies identifying variants in different
transcription factor binding sites in the F9 promoter
including the androgen-responsive element (ARE), hepa-
tocyte nuclear factor 4α (HNF4α), one cut homeobox
(ONECUT1/2) and CCAAT/enhancing-binding protein α
(C/EBPα) binding sites.21,22 HNF4α is a liver-enriched
member of the nuclear receptor superfamily of ligand-
dependent transcription factors and has been associated
with several disorders, including diabetes, atherosclero-
sis, hepatitis, cancer, and hemophilia.23 Promoter analyses
have identified at least 140 genes with HNF4α binding
sites. A recent, more detailed analysis using protein bind-
ing microarrays identified an additional 1,400 potential
binding sites.24,25 Hence, HNF4α plays an important role in
the regulation of numerous genes especially in the main-
tenance of many liver-specific functions. Liver-specific
HNF4α-null mice have been used to study the involve-
ment of hepatic HNF4α in blood coagulation. In the
murine model it was shown that expression of factors V,
XI, XII, and XIIIB depends directly on hepatic HNF4α and
FIX expression was decreased with significantly pro-
longed activated partial thromboplastin time (aPTT).26
Ten of the so far identified 28 5’-UTR variants (35.7%) are
located within the overlapping binding sites of the andro-
gen receptor (AR) and HNF4α in the human F9 promot-
er.4,21 Four variants at positions -21, -20 and -19 only affect
HNF4α binding and all of them have been shown to
cause hemophilia B Leyden.19,27-30 The remaining six vari-
ants at positions -26, -24 and -23, located in the overlap-
ping region, cause the so-called hemophilia B
Brandenburg.31,32 Unlike the classical hemophilia B
Leyden, FIX levels in patients with these variants cannot
be restored by testosterone-driven AR activity and
remain low after puberty with no clinical recovery.21,32
Methods
Animals and genomic DNA isolation
Canine blood and/or hair samples were collected by local vet-
erinarians. The collection of samples was approved by the Lower
Saxony State Office for Consumer Protection and Food Safety
(33.19-42502-05-15A506) according to §8a Abs. 1 Nr. 2 of the
German Animal Protection Law (TierSchG). Blood collected into
EDTA and/or hair samples were provided by different Hovawart
and dog breeders with written consent from the dogs’ owners.
DNA was extracted from 30-50 hair roots using the QIAamp
DNA Mini Kit (Qiagen, Hilden, Germany) according to the man-
ufacturer‘s instructions.33 A salting out procedure was used to
obtain DNA from the EDTA blood samples.34 Additional DNA
samples deposited with the Institute of Veterinary Medicine were
used as controls. All samples were pseudonymized using internal
identities.
Next-generation sequencing and genotyping
DNA from animals #4 and #6 was used for next-generation
sequencing on an Illumina HiSeq2500. The quality of the fastq-
files was analyzed using FastQC 0.11.7.35 Total reads of
1,029,601,630 (#4; sequencing depth 51x) and 1,000,503,256 (#6;
sequencing depth 50x) were obtained and mapped to the refer-
ence canine F9 gene (NC_006621.3, region 109,501,341 to
109,533,798; CanFam3.1) using DNASTAR Lasergene Genomics
Suite SeqMan NGen 15.2.0 (130).36-40
Targeted genotyping of the promoter deletion was done by
polymerase chain reaction (PCR) amplification with primers
cfa_F9_Ex1_F (5’-CCACTGAGGGAGATGGACAC-3’) and
cfa_F9_Ex1_R (5’-CCCACATGCTGACGACTAGA-3’) resulting
in a fragment of 328 bp (wildtype) or 327 bp (deletion) spanning
the variant position. The resulting PCR products were either
directly sequenced on an ABI 3730 Genetic Analyzer (Thermo
Fisher Scientific, Basel, Switzerland) or genotypes were deter-
mined by restriction fragment length polymorphism analysis after
cleavage with RsaI. The wildtype allele generated two fragments
of 52 bp and 276 bp while the allele with the deletion remained
uncut.
Electrophoretic mobility shift assay 
For the electrophoretic mobility shift assay, biotin-labeled, dou-
ble-stranded wildtype (cfa_F9n_wt_Biotin: 5’-CAGAAGTAAAT-
ACAGCTCAACTTGTACTTTGGAACAACTGGTCAACC-3’)
and mutated (cfa_F9n_mut_Biotin: 5’-CCAGAAGTAAAT-
ACAGCTCAACTTGTATTTGGAACAACTGGTCAACC-3’)
oligonucleotides were synthesized (Integrated DNA Technologies
IDT, Leuven, Belgium) harboring the overlapping HNF4α and AR
binding sites (underlined). The position of the deleted C-
nucleotide is indicated in bold and italics. Recombinant human
HNF4α and human AR overexpression lysate were purchased
from Origene Technologies Inc. (Rockville, MD, USA).
DNA was detected using the Chemiluminescent Nucleic Acid
Detection Module Kit (Thermo Scientific, USA) with minor mod-
ifications, i.e. membranes were incubated for 1 min in the sub-
strate working solution.
Luciferase assay
pGL3 Luciferase Reporter Vectors (pGL3-Basic, pGL3-Control)
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were used for the luciferase assay (Promega, Mannheim,
Germany). The wildtype F9 promoter fragment (971 bp wildtype)
was generated by PCR using primers cfa9_HindIII_F_neu (5’-
C G TA G A C T TA G C A C T G T T C AAAGCTTCACACA-
CACAGTTCTTAAAT-3’) and cfa9_HindIII_R_neu (5’-ATGGC-
TAGCAACCGTCTAAGAAGCTTAATTGTGCAAGGAG-
CAAGG-3’). The mutated F9 promoter fragment (970 bp) was
generated by PCR using primers cfa9_HindIII_F (5’-ATCGT-
CAAGCTTCACACACACAGTTCTTAAAT-3’) and
cfa9_HindIII_R (5’-CGTACGAAGCTTAATTGTGCAAGGAG-
CAAGG-3’). For cloning into the HindIII restriction site of pGL3,
primers were designed with an unspecific random 5’-tag (italics)
followed by a HindIII restriction site (underlined) (Online
Supplementary Figure S1). DNA from female carrier #6 served as a
template for amplification. Low expression levels of C/EBP in Hep
G2 cells were complemented by co-transfection of a C/EBPα
expression vector.22 Data are presented as relative response ratios.41
A Mann-Whitney U test was used to determine statistical signifi-
cance. Values were considered statistically significant when
P<0.05 (weakly significant), P<0.01 (medium-strength signifi-
cance) and P<0.001 (strongly significant).
Other methods
Further details of the study methods are given in the Online
Supplementary Appendix.
Results
Hemophilias are rare diseases in dogs and hence it was
rather coincidental that a case in a Hovawart (#3, Figure 1)
was reported to us. With the reconstruction of the pedi-
gree using the online dog breed database and pedigree
data of individual dogs provided by the owners it was
possible to trace the disease back to the female carrier #39
(Figure 1, Online Supplementary Figure S2).42 In the studied
family the hemophilia was transmitted to animals #19, #4
and #6. Bitch #19 had one litter with three hemophilic
males (#48, #51, #53). Bitches #4 and #6 had litters with
one affected male each, #60 and #3, respectively. Although
DNA samples from animals #48, #51, #53 and #60 were
not available, blood parameters and medical reports about
recurrent hemorrhagic episodes were provided (Online
Christmas disease in a Hovawart family
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Figure 1. Pedigree section of the hemo-
philia B Leyden Hovawart family and
DNA sequence comparison of the
mutant hepatocyte nuclear factor
4α/androgen receptor binding site in
the promoter of canine F9 in the hemo-
philic male (#3) and relatives (#4
grandmother, #5 sister, #6 mother, #7
cousin). Pedigree symbols are accord-
ing to the standardized human pedigree
nomenclature.61 Individuals are pseudo-
nymized using internal identities. DNA
samples were available from individuals
indicated with an arrow. DNA
sequences of heterozygous bitches #4
and #6 (female carriers) show overlap-
ping peaks with similar heights 5’ of the
deletion position. For males #48, #51,
#53 and #60, signs of hemophilia
(Online Supplementary Table S1) were
reported and the dogs had to be eutha-
nized after recurrent hemorrhages. Xm:
maternal X chromosome; Xp: paternal X
chromosome; HNF4α: hepatocyte
nuclear factor 4α binding site (consen-
sus sequence: 5’-TGNACTTTG-3’);21,48
AR: 3’-part of the androgen receptor
binding site (consensus sequence: 5’-
AGNACANNNTGTNCT-3’).21,48
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Supplementary Table S1). These males had increased aPTT
ratios of 2.93 (#53) to 4.76 (#51) indicative of defects in the
intrinsic coagulation pathway and also reduced FIX con-
centrations in the blood as is normally the case in hemo-
philia B. The affected dog #3 presented only 2% of the
standard FIX concentration. The female carriers #4 and #6
showed aPTT ratios within the reference range. FIX con-
centrations, however, were slightly below the reference
range (#6). This was not surprising as it has been shown
that minute reductions in FIX concentrations might not
always be reflected in an aPTT increase because of the
sensitivity of commercial reagents.43 The clinical signs
together with the blood coagulation parameters and X-
linked transmission supported the diagnosis of hemophil-
ia B. The definite clinical diagnosis prompted us to search
for the molecular cause initially on the DNA level. The
canine F9 gene is located on chromosome X (CFAX)
between positions 109,501,341 (transcription start site)
and 109,533,798 and has a length of 32,458 bp
(NC_006621.3, CanFam3.1). The canine F9 gene, similarly
to that of other mammals, has eight exons with an open
reading frame of 1,356 bp coding for 452 amino acids.44
DNA of female carriers #4 and #6 was subjected to whole
genome sequencing and aligned to the canine reference F9
gene sequence. Surprisingly, only six sequence variants
outside the coding regions of F9 were identified (Table 1).
Five variants were located in introns and were excluded as
the cause of the hemophilia B in the Hovawarts because
these variants were also detected in unaffected controls.
The remaining variant (deletion) was located in the pro-
moter of F9 73 bp upstream of the start codon (Online
Supplementary Figures S1 and S3). As this deletion was
located within a putative transcription factor binding site
of HNF4α and AR, which had been shown in humans to
be important for F9 expression and mutated in hemophilia
B Leyden and Brandenburg,31,32 this position was analyzed
in more detail.
Figure 1 shows the segregation of the nucleotide deletion
in the affected Hovawart family. The female carriers #4
and #6 were heterozygous, as evidenced by the overlap-
ping peaks with similar heights 5’ of the deletion position.
The affected male #3 was hemizygous for the deleted
allele whereas his sister #5 and cousin #7 were homozy-
gous wildtype. Genotyping of 1,298 dogs (including 83 dif-
ferent breeds, 720 unrelated Hovawarts, and 12 Hovawart
family members) demonstrated the occurrence of the dele-
tion only among members of the affected Hovawart family
(Table 2, Online Supplementary Table S2). To provide proof
that the deletion represented the causative genetic variant
and resulted in the low expression of F9, functional analy-
ses using electrophoretic mobility shift and luciferase
reporter assays were performed.
As shown in Figure 2, no binding of recombinant HNF4α
to the mutated promoter region was detected. On the
other hand, the AR lysate clearly showed binding to both
fragments and hence the deletion seems not to influence
AR binding to the androgen-responsive element in the
canine F9 promoter. To analyze the effect of the promoter
variant on F9 expression, wildtype and mutated promoter
fragment luciferase constructs were transfected into Hep
G2 cells. As shown in Figure 3 the mutated promoter frag-
ment resulted in a statistically highly significant (P=2.2x10-
6) reduction of the relative response ratio to approximately
34.6% of the wildtype promoter in the presence of C/EBP
(+ C/EBP). C/EBP is clearly also an important transcription
factor in the regulation of the canine F9 promoter as shown
when C/EBP was not co-transfected (- C/EBP). In the
absence of C/EBP the relative response ratio of the wild-
type promoter was 29.8%. On the other hand there were
no significant differences between the mutated promoter
fragment (+/- C/EBP) and the wildtype promoter fragment
(- C/EBP). As for variants of the HNF4α site, disruption of
the C/EBP binding site has also been shown to be causative
for hemophilia B in humans.45,46
Discussion
As in humans, hemophilia A and B are also rare diseases
in dogs caused by sequence variants in the coagulation
B. Brenig et al.
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Table 1. DNA sequence variants in the canine F9 gene determined by next-generation sequencing of DNA of animals #4 and #6.
Position                          Ref/Alta                              Gene region                                HGVSb g.
X:109501492                              C/-                                     5’-flanking region                                   NC_006621.3:g.109501492delC
X:109504229                              C/-                                              intron 1                                            NC_006621.3:g.109504229delC
X:109505462                             -/AG                                             intron 1                                            NC_006621.3:109505462_109505463insAG
X:109507446                               -/A                                              intron 2                                            NC_006621.3:109507446_109507446insA
X:109510986                              G/A                                              intron 3                                            NC_006621.3:g.109510986G>A
X:109524055                              A/G                                              intron 6                                            NC_006621.3:g.109524055A>G
aRef/Alt: reference nucleotide/alternate nucleotide; bHGVS: Human Genome Variation Society (http://www.hgvs.org).
Table 2. F9 genotype frequencies
                                                                                                    Hovawart                                                                                             Other breedsb
Genotype             HBa affected (n=1)                  HB carrier (n=2)           Control, related (n=12)               Control, unknown              Controls (n= 567)
                                                                                                                                                               relationship (n= 720)                         
C/C                                                                                                                                                     12                                                    720                                             567
C/-                                                                                                    2                                                                                                                                                             
-/-                                               1                                                                                                                                                                                                                    
aHB: hemophilia B; bdog breeds used as controls are listed in Online Supplementary Table S2.
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factor VIII (F8) and IX (F9) gene, respectively.47 Since the
1960s cases of canine hemophilia B have been reported
and in 1989 the first description of the molecular cause in
a Cairn Terrier population at the Francis Owen Blood
Research Laboratory was published.5,8,9,44
Since then only six further types of variants, all of them
affecting the coding region of the F9 gene, i.e. deletions,
insertions, missense variants, have been described as
causative for canine hemophilia B.10-12,15,16 The identifica-
tion of a causative promoter variant in the Hovawart dogs
described here is therefore unique in two respects: it is the
first regulatory variant described in dogs and secondly this
variant resembles a specific subtype of hemophilia B,
known as hemophilia B Leyden, in humans.21 Hitherto, 21
distinct variants in the human F9 promoter have been
determined in families affected by hemophilia B Leyden.48
These variants cluster in the so-called Leyden-specific
region (LSR) and interfere with the binding of different
transcription factors, e.g. AR, HNF4α, ONECUT, and
C/EBPα.49 The deletion identified in the Hovawart dogs
was located 73 bp upstream of the start codon of the
canine F9 gene corresponding to position -23 in the third
human promoter cluster harboring the overlapping bind-
ing sites of AR and HNF4α.48 Similar to analyses in
humans, it was possible to show by electrophoretic
mobility shift assay that the deletion in the canine pro-
moter abolished HNF4α binding because it affects the
highly conserved core sequence of the HNF4α binding
motif.24 On the other hand, binding of AR was not affect-
ed. This might be due to the fact that AR DNA-binding
Christmas disease in a Hovawart family
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Figure 3. Dual-luciferase reporter analysis of F9 promoter activities in Hep G2
cells. Box and whisker plot showing the change of relative response ratios (RRR)
between the wildtype (F9-wt) and mutant promoter (F9-mut) gene constructs.
The lines in the boxes represent the medians. Whiskers indicate minimum and
maximum RRR values. Values were normalized as described in the Online
Supplementary Methods. P-values are indicated.
Figure 2. Analysis of hepatocyte nuclear factor 4α and androgen receptor binding of wildtype and mutated F9 promoter regions using an electrophoretic mobility
shift assay. (A, B) Human hepatocyte nuclear factor 4α (HNF4α) and (B) androgen receptor (AR) were used to bind biotin-labeled wildtype and mutated F9 promoter
fragments (F9-wt, F9-mut). Specific shifted bands (solid arrowheads) are detected in lane 2 (A) for HNF4α and lanes 5 and 6 (B) for AR. To test specificity, binding
reactions were also performed using bovine serum albumin [BSA; lanes 3 and 4 (A), lanes 1 and 2 (B)]. In lanes 5 and 6 (A) and lanes 3 and 4 (B) no protein was
added. Binding reactions were separated on 12% Tris-Glycine gels. X-ray films were cropped using GIMP 2.8.22. The 70 kDa protein marker band (PageRuler
Prestained Protein Ladder, Fermentas) is indicated with an asterisk (lane M). The open arrowhead indicates unbound, free DNA.
A B
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sites display an exceptional amount of sequence
variation.50 Although the C-deletion is located in the con-
sensus TGTNCT-motif of class I AR-binding sites several
alternative motives, e.g. TGTTTC in the stomatin-like
protein 3 gene or TGTATC in the prostate-specific antigen
gene enhancer III region, have been reported.50-52
Therefore, it can be assumed that the affected males
would have recovered from hemophilia during puberty.
To what extent a sex- or possibly also age-dependent ame-
lioration of the hemophilia B Leyden, as described in
humans and also a mouse model, might be present in the
affected Hovawarts remains to be determined.49,53 In this
respect the Hovawart family could also be of interest as a
model in the comparative analysis of age-dependent nor-
malization of F9 expression in symptomatic carriers of
hemophilia B Leyden in humans.
To analyze whether the deletion not only affected
HNF4α binding but also resulted in a downregulation of
F9 expression, we performed luciferase assays. Although
relative response ratios do not directly reflect F9mRNA or
FIX levels in vivo, silencing of the promoter activity due to
the deletion was obvious from these experiments. Similar
findings have been made using HNF4α-null mice.26 In the
murine model it was shown that expression of factors V,
XI, XII, and XIIIB directly depends on hepatic HNF4α.
Northern blot analysis also demonstrated that F9 expres-
sion was decreased with a significantly prolonged aPTT in
the HNF4α-null mice.26 The finding that F9 expression
was not completely dependent on HNF4α is in agreement
with the observation that control of F9 transcription in
mice and humans is complex and depends on a plethora of
factors.26 For instance, in earlier studies it was shown,
using DNaseI footprinting, that there are further binding
sites of HNF4α and other factors, e.g. ARP1, COUP/Ear3,
in the human F9 promoter influencing F9 expression.54
However, the classical HNF4α binding site at position -26
to -19 only binds HNF4α. When analyzing the canine F9
promoter using transcription factor binding site prediction
algorithms, further potential binding motifs for HNF4α
and other transcription factors were predicted (data not
shown).55-57 As ectopic expression of F9 in vivo can be
excluded or at least ignored according to recent RNA-
sequencing analyses,58 a remaining reduced hepatic activi-
ty of the mutated promoter is in agreement with the clin-
ical findings of residual FIX activity in the affected males
(Online Supplementary Table S1) and the results of the elec-
trophoretic mobility shift assay showing binding of AR in
androgen-dependent promoter activation.
In summary, we have identified and elucidated the
causative genetic variant for hemophilia B Leyden in
Hovawarts. This is the first report on a single nucleotide
deletion within the binding sites of HNF4α and AR in the
F9 promoter causing hemophilia B Leyden in dogs. As the
deletion only abolishes the binding of HNF4α, it can be
assumed that male dogs will most likely recover during
puberty, as reported in humans.30,59,60 However, to prevent
any risk of a further propagation of the disorder, genotyp-
ing of females is recommended in further breeding.
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Coagulation assays and FIX activity measurement 
APTT (activated partial thromboplastin time) was measured coagulometrically using 
different commercially available activating reagents according to the manufacturer's 
test instructions.  To standardize measurement results performed in different 
laboratories, ratio values (aPTT patient/median aPTT of healthy dogs) were calculated 
and reported. FIX activity was measured coagulometrically using human FIX deficient 
plasma and a commercial human aPTT reagent for activation. Canine pooled plasmas 
were used as reference (activity defined as 100 %). 
 
Next generation sequencing (NGS) and genotyping 
A 450 bp library was prepared from genomic DNA with the NEBNext Ultra DNA Library 
Prep Kit for Illumina (New England Biolabs GmbH, Frankfurt, Germany) following the 
manufacturer's instructions. Library quality was evaluated with Agilent2100 Bioanalyzer. 
The following assembly options were used: mer-size 31 nt, min. match percentage 98, 
high layout stringency, min. aligned length 120 nt, min. layout length 50 nt, max. gap 
size 5 nt. Duplicate reads were combined and clonal reads removed. For #4 4,590 and 
for #6 4,982 consistent paired reads were assembled. The sample wise insert size 
metrics for high quality aligned reads was median pair distance 383.1 bp (SD 117.46 bp, 
min. distance 151 bp, max. distance 894 bp) for #4 and 383.9 bp (SD 103.55 bp, min. 
distance 153 bp, max. distance 882 bp) for #6. 
 
Electrophoretic mobility shift assay (EMSA) 
Binding reactions included 2 μL 10 x binding buffer (100 mM Tris, 10 mM EDTA, 1 M KCl, 
60% v/v Glycerol (86% solution), 0.1 mg/ml BSA, 0.5% Triton X-100, 1mM DTT; pH 7.5), 2 
μg poly(dI-dC) and 1.2 μg human HNF4α or 4 µg poly(dI-dC) and 5 µg human AR lysate. 
As negative controls 1 pmol duplex DNA oligos were incubated without protein or with 1 
μg BSA. Binding reactions were pre-incubated for 20 min on ice followed by 1 hour at 
room temperature after adding 1 pmol biotin-end labelled double-stranded 
oligonucleotide probes. The mixtures were loaded onto 12% Tris-Glycine gels 
(Invitrogen, USA). After electrophoresis at 80 V for 90 min (HNF4α) or 2 hours (AR), gels 
were blotted onto PVDF membranes (GE Healthcare Life Sciences, Germany) using a wet 
blotter for 30 min at 100 V. Membranes were crosslinked at 120 mJ/cm2 using a 
commercial UV-light crosslinking instrument equipped with 254 nm bulbs for 1 minute. 
 
Luciferase-Assay 
Promoter fragment design was geared to an equivalence of the canine genomic 
situation choosing a respective distance between NC_006621.3:g.109,501,492delC and 
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the luciferase start codon. Recombinant pGL3 vectors were used for transformation of 
E. coli XL1-Blue according to the manufacturer´s protocol. Plasmid DNA of 17 colonies of 
pGL3Basic+970bpinsertF9_MT and 37 colonies of pGL3Basic+971bpinsertF9_WT were 
isolated using Promega PureYield Plasmid Miniprep Kit (Promega, Mannheim, Germany) 
and sequenced for validation. A validated clone of each construct was incubated in LB-
medium and plasmid DNA was isolated using Qiagen Plasmid Maxi Kit (Qiagen, Hilden, 
Germany). 
For analysis of promoter activity human hepatoma derived cell line Hep G2 (ATCC HB-
8065) was cultivated in Roti-CELL DMEM High Glucose (Carl Roth GmbH, Karlsruhe, 
Germany) 1. Constructs were transfected using Effectene Transfection Reagent (Qiagen, 
Hilden, Germany). Firefly and Renilla luciferase luminescence was measured using the 
Dual-Glo Luciferase Assay System (Promega, Mannheim, Germany) on a Tecan GENios 
Pro 96/384 Multifunction Microplate Reader (Tecan GmbH, Crailsheim, Germany) with 
the analysis software XFlour v4.64 after cell lysis with Passive Lysis 5X Buffer (Promega, 
Mannheim, Germany). For normalization Renilla luciferase activity was measured by co-
transfecting phRL-TK(Int-) (Promega, Mannheim, Germany). Experiments were repeated 
5-times with two measurements each. Background luminescence values were 
subtracted from raw luminescence values. Renilla luciferase activities were used for 







Figure S1. Structure of the pGL3 Luciferase Reporter Vector constructs 
Fragments of the canine F9 gene wild type (971 bp) and mutant (970 bp) promoter were 
amplified and cloned into the HindIII restriction site of the pGL3-Basic Vector multiple 
cloning site upstream of the luc+ coding region. The distance of the C-deletion within 
the overlapping AR/HNF4𝛼 binding sites 73 bp upstream the start codons (indicated in 
bold red) and the potential binding sites of ONECUT and C/EBP were cloned so that the 
distances of the positions in the promoter inserts to the luciferase reporter gene exactly 



















Figure S2. Detailed pedigree of the affected Hovawart family 
The ancestry of the affected Hovawart #3 was reconstructed using the online dog breed 
database "Working dog" and pedigree data of individual dogs provided by the owners 3. 
The pedigree was drawn using Pedigraph 4. Males are indicted with squares, females 
with circles. Pseudonymized individual dog numbers are given within the pedigree 
symbols.  
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Figure S3. Sequence comparison of the human and canine F9 promoter region 
including exon 1 
Position 109501382 of the canine F9 promoter (cF9) corresponds to accession number 
ENSCAFG00000018998 (CM000039.3, CanFam3.1) 5. Position 139530603 of the human 
F9 promoter (hF9) corresponds to accession number NC_000023.11 (GRCh38.p12) 5, 6. 
The start codons of exon 1 are indicated in red 5. Amino acids of the first exons are 
shown in 3-letter code below the corresponding DNA sequence. Identical nucleotide 
positions are depicted with colons. Consensus sequences of transcription factor binding 
sites identified in the human F9 promoter are shown in bold and/or green: NF1-L 
(Nuclear factor-1 liver) 5, 7, AR (Androgen receptor) 8, 9, HNF4𝛼 (Hepatocyte nuclear 
factor 4𝛼) 9-11, ONECUT (ONECUT homeobox transcription factor 1 and 2) 5, 9, 11, 12, C/EBP 
(CCAAT/enhancer-binding protein alpha) 5, 7, 9, 11. In the overlapping binding sites of AR 
and HNF4𝛼, the binding site of HNF4𝛼 is also underlined. The position (73 bp upstream 
of the ATG) of the C-deletion (-/C (del)) causative for Hemophilia B Leyden in the 
Hovawart family is indicated. The predicted HNF4𝛼 binding site in the canine F9 
promoter using the online database PROMO 3.0 is shown in bold blue 13, 14. The oligo 
109501382
|   
cF9 AAGATGAACA CTGCCTACAC TCTTAACCCA AGAGGCCACT GGAAATAGCC
:  :  :   ::   :  :::  :::: :::::::: : :::::::: :
hF9 GACCACTGCC CATTCTCTTC ACTTGTCCCA AGAGGCCATT GGAAATAGTC
|                                           NF1-L
139530603
cF9 CAAAGACCCA CTGAGGGAGA TGGACACTGT TTCCCAGAAG TAAATACAGC
:::::::::: :::::::::: :::::: : : :::::::::: ::::::::::
hF9 CAAAGACCCA TTGAGGGAGA TGGACATTAT TTCCCAGAAG TAAATACAGC
-/C (del)
|
cF9 TCAACTTGTA CTTTGGAACA ACTGGTCAAC CTTGCTCCTT GCACAATTCA
::: :::::: :::::: ::: :::  :: :: ::: :  :::  ::::::   
hF9 TCAGCTTGTA CTTTGGTACA ACTAATCGAC CTTACCACTT TCACAATCTG
AR HNF4a ONECUT C/EBP 
• • • •••             ••     |    •• ••  ••
-26    -20             -6     +1          +13
cF9 TCAGCAAAGG TTAGGCAGCG CCTGAATAGG ATCATGGCAG AAGCATCGGG
:::::::: ::: :::::: : :::: : : :::MetAlaG luAlaSerGl
hF9 CTAGCAAAGG TTATGCAGCG CGTGAACATG ATCATGGCAG AATCACCAGG
MetGlnAr gValAsnMet IleMetAlaG luSerProGl
cF9 CCTCGTCACC GTCTGCCTTT TAGGATATCT ACTCAGTGCC GAATGTGCAG
yLeuValThr ValCysLeuL euGlyTyrLe uLeuSerAla GluCysAla
hF9 CCTCATCACC ATCTGCCTTT TAGGATATCT ACTCAGTGCT GAATGTACAG
yLeuIleThr IleCysLeuL euGlyTyrLe uLeuSerAla GluCysThr
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used for EMSA is underlined in cF9. The transcription start site of the human F9 gene is 
indicated with +1 5, 7. Bullet points and numbers below the human F9 promoter DNA 
sequence mark nucleotide positions that have been shown to associated hemophilia B 
(+6: T>A 9, +7: T>C 9, +8: T>C 9, +9: T>G 9, +12: A>G 9, +13: A>G, A>C or delA 7, 9), 
hemophilia B Leyden (-5: A>T or A>G 12, -6: G>A or G>C 12, -19: G>C 12, -20: T>A or T>C 8, 
11, 12, -21: T>G 10, 12, -23: C>T or C>G 12, -24: A>G 12) and hemophilia B Brandenburg (-26: 
G>C, G>T or G>A 8, 9, 11, 12).  
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Table S1. Determination of hemophilia relevant blood parameters and medical reports 
IDa) Sex aPTT ratiob) FIX (%)c) Medical report 
#3 m NDd) 2 severe bleeding after chipping, blood 
transfusion, death caused by blood loss 
#4 f 1.08 92  
#5 f 1.1 64  
#6 f 1.1 58  
#7 m 1.03 83  
#48e) m 4.2 3 slight bleeding during second dentition, 
lameness/joint problems (age 4 months), 
several blood transfusions 
#50 m 1.22 NDd)  
#51e) m 4.76 70 umbilical hernia with internal bleeding after 
surgery, blood transfusion, minor bleeding 
episodes 
#52 m 3.19 110  
#53e) m 2.93 NDd) recurrent slight bleeding, prolonged bleeding 
during second dentition, lameness/joint 
problems 
#54 m 1.09 55  
#60e) m 4.47 5 severe bleeding after first vaccination (age 8 
weeks) 
Control 1 m 1.0 83 healthy unrelated Hovawart control 
Control 2 f 0.98 >100 healthy unrelated Hovawart control 
a) Animal IDs refer to Fig 1; b) aPTT ratio: reference range 0.88-1.14; c) FIX (%): FIX % of 
standard (reference range: 75-140%); d) ND: not determined; e) #48, #51, #53 and #60 
had been euthanized.  
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Table S2. Dog breeds used for determination of F9 genotype frequencies shown in 
Table 2 
Airedale Terrier (n=1), Akita Inu (n=8), Alaskan Malamute (n=1), Appenzell Cattle Dog 
(n=8), Australian Cattle Dog (n=8), Australian Shepherd (n=8), Barbet (n=8), Barzoi (n=8), 
Bavarian Mountain Scent Hound (n=3), Beagle (n=8), Bearded Collie (n=8), Belgian 
Shepherd Dog (n=15), Bernese Mountain Dog (n=8), Border Collie (n=11), Boston Terrier 
(n=8), Boxer (n=2), Briard (n=8), Cairn Terrier (n=8), Canadian Sheepdog (n=1), Catalan 
Sheepdog (n=1), Chinese Crested Dog (n=8), Chihuahua (n=7), Cocker Spaniel (n=1), 
Dachshund (n=11), Dalmatian (n=1), German Hound (n=2), Doberman (n=8), Elo (n=8), 
Entlebuch Cattle Dog (n=8), Eurasier (n=1), Flat Coated Retriever (n=8), Fox Terrier (n=1), 
French Bulldog (n=9), German Shepherd (n=12), German Shorthaired Pointer (n=2), 
German Spaniel (n=10), Giant Schnauzer (n=6), Giant Spitz (n=8), Golden Retriever 
(n=15), Great Dane (n=8), Greyhound (n=8), Irish Terrier (n=8), Jack Russel Terrier 
(n=10), Keeshound (n=8), Kromfohrländer (n=8), Labrador Retriever (n=10), Lagotto 
Romagnolo (n=8), Landseer (n=8), Leonberger (n=8), Magyar Viszla (n=1), Maltese (n=2), 
Xoloitzcuintle (n=6), Miniature Spitz (n=8), Miniature Pinscher (n=8), Miniature Poodle 
(n=2), Mudi (n=7), Mongrel (n=34), Newfoundland (n=7), Norwich Terrier (n=8), Nova 
Scotia Duck Tolling Retriever (n=8), Peruvian Hairless Dog (n=6), Polish Lowland 
Sheepdog (n=8), Pomeranian (n=8), Poodle (n=10), Portuguese Sheepdog (n=8), 
Pudelpointer (n=1), Pyrenean Sheepdog smoothfaced (n=2), Rhodesian Ridgeback (n=8), 
Saluki (n=4), Schapendoes (n=10), Scottish Terrier (n=8), Sibirian Husky (n=9), Shi Tzu 
(n=1), Spanish Water Dog (n=8), St. Bernard (n=8), Tibet Terrier (n=8), Welsh Terrier 
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Abstract: Congenital deafness is prevalent among modern dog breeds, including Australian Stumpy
Tail Cattle Dogs (ASCD). However, in ASCD, no causative gene has been identified so far. Therefore,
we performed a genome-wide association study (GWAS) and whole genome sequencing (WGS)
of affected and normal individuals. For GWAS, 3 bilateral deaf ASCDs, 43 herding dogs, and
one unaffected ASCD were used, resulting in 13 significantly associated loci on 6 chromosomes,
i.e., CFA3, 8, 17, 23, 28, and 37. CFA37 harbored a region with the most significant association
(−log10(9.54 × 10−21) = 20.02) as well as 7 of the 13 associated loci. For whole genome sequencing,
the same three affected ASCDs and one unaffected ASCD were used. The WGS data were compared
with 722 canine controls and filtered for protein coding and non-synonymous variants, resulting in
four missense variants present only in the affected dogs. Using effect prediction tools, two variants
remained with predicted deleterious effects within the Heart development protein with EGF like
domains 1 (HEG1) gene (NC_006615.3: g.28028412G>C; XP_022269716.1: p.His531Asp) and Kruppel-
like factor 7 (KLF7) gene (NC_006619.3: g.15562684G>A; XP_022270984.1: p.Leu173Phe). Due to its
function as a regulator in heart and vessel formation and cardiovascular development, HEG1 was
excluded as a candidate gene. On the other hand, KLF7 plays a crucial role in the nervous system, is
expressed in the otic placode, and is reported to be involved in inner ear development. 55 additional
ASCD samples (28 deaf and 27 normal hearing dogs) were genotyped for the KLF7 variant, and the
variant remained significantly associated with deafness in ASCD (p = 0.014). Furthermore, 24 dogs
with heterozygous or homozygous mutations were detected, including 18 deaf dogs. The penetrance
was calculated to be 0.75, which is in agreement with previous reports. In conclusion, KLF7 is a
promising candidate gene causative for ASCD deafness.
Keywords: deafness; kruppel-like factor 7; genome wide association study; Australian stumpy tail
cattle dog; brainstem auditory evoked response
1. Introduction
Deafness can cause several inconveniences for dogs (Canis familiaris, CFA), as more
attention is required to avoid undetected danger. Deaf dogs are not suitable as work-
ing dogs because their training is more challenging than for normal hearing dogs. In
addition, they are more likely to be startled and show more tendency to bite [1]. More
than 100 modern dog breeds have been reported to be affected by congenital deafness [2].
Hence, deafness seems to be a common disorder among dogs, particularly in breeds such
as the Dalmatian, Bull Terrier, English Setter, English Cocker Spaniel, and Australian Cat-
tle Dog [3]. Hearing loss or deafness can be categorized mainly by five criteria in dogs:
(1) Cause (genetic or nongenetic, inherited or acquired); (2) association with other diseases
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or phenotypes (syndromic or non-syndromic); (3) number of affected ears (unilateral or
bilateral); (4) degree of loss (partial or total); and (5) site of pathology (peripheral or cen-
tral) [4]. Peripheral deafness can also be classified as inherited or acquired, congenital
or late onset, and sensorineural or conductive. In dogs, three classifications of deafness
are commonly seen, including inherited congenital sensorineural, acquired later-onset
sensorineural, and acquired later-onset conductive deafness [5].
In dogs, congenital sensorineural deafness is common, resulting in total deafness in
young puppies that is either unilateral or bilateral. Sensorineural deafness results from
dysfunction of cochlea or spiral ganglion. While it can be a degenerative process that
relates to aging, noise trauma, exposure to therapeutic drugs that have ototoxic side effects,
and chronic conditions [6], it is frequently inherited and so linked to one or more genetic
mutations. Some morphological studies in dogs showed congenital sensorineural deafness
manifested hypoplasia or aplasia of the sensory cells in the organ of Corti, stria vascularis,
macula saccule, solidification, and calcification of tectorial membrane [7,8]. Congenital
sensorineural deafness is usually, but not always, related to pigmentation genes in some
breeds [3].
Diagnosis of canine deafness usually consists of behavioral or electrodiagnostic test-
ing. The behavioral testing is often unreliable, especially for the unilateral deafness or
partial hearing impairment cases. The response of dogs may be affected by psychology
(e.g., anxiety or loss of interest) and other senses (e.g., visual cues, vibration, or even air
movement) [9]. The brainstem auditory evoked response (BAER) is the averaged record of
the electrical activity of the auditory pathway in response to externally applied acoustic
stimuli [10]. Compared with behavioral testing, the BAER test is an objective diagnostic
method, with the advantages of being easy to record, noninvasive, safe, short test time,
and giving reliable results [11].
The Australian Stumpy Tail Cattle Dog (ASCD) is a unique breed with a natural
bob-tail, which should be distinguished from the Australian Cattle Dog breed. ASCD is
alert, watchful and obedient, and talented in working and controlling cattle. It has been
recognized as a standardized breed since 1963 by the Australian National Kennel Council.
For a long time, general opinion held that the origins of the Australian Stumpy Tail Cattle
Dog arose from European herding dogs and the Australian Dingo. However, recently it
has been suggested that the ancestors of the Australian Stumpy Tail Cattle Dog and the
Australian Cattle Dog, sharing a common origin, arrived in Australia with early free settlers,
as their unidentified companions, between 1788 and c. 1800 (Clark, Noreen R. A Dog for the
Job. (in prep. 2020)). Each pup should undergo a BAER test because this breed has a high
deafness prevalence (https://www.akc.org/dog-breeds/australian-stump-tail-cattle-dog/
(accessed on 24 March 2021)). A research study of 315 ASCDs showed the incidence of
congenital sensorineural deafness was 17.8% [12]. There was no evidence that congenital
sensorineural deafness in ASCD has a left/right asymmetry or a sex-specific pattern, but
there was a significant correlation between red (over blue) coat color and deafness [12].
No unique causative variants have been identified so far for any dog breeds, possibly
in part due to the fact that deafness appears to be a comparatively heterogenous disease as
described above. In addition, there are several hypotheses about the inheritance pattern
of congenital sensorineural deafness (reviewed by [1]). In Border Collies, for instance,
Ubiquitin Specific Peptidase 31 (USP31) and RB Binding Protein 6 (RBBP6) have been
associated with adult-onset deafness [13], whereas in the Doberman Pinscher, an insertion
in Protein Tyrosine Phosphatase Receptor Type Q (PTPRQ) and a missense variant in
Myosin VIIA (MYO7A) have been shown to be causative for a form of deafness that
includes vestibular disease [14,15]. Although chromosome 2 (CFA2), 6, 14, 17, 27, and 29
have been associated with hearing loss in Dalmatians, no causative variants have been
identified so far [16].
In ASCD, congenital sensorineural deafness has been linked to a chromosomal region
on CFA10 [12]. However, within a potential candidate gene Sry-related Hmg-box gene 10
(SOX10) located in this region, no causative alterations were detected. A recent genome-
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wide association study (GWAS) reported 14 chromosomes that were significantly associated
with deafness in three canine breeds, and CFA3 was significantly associated with bilateral
deafness in Australian Cattle Dogs [17]. In this study, three suggestive candidate genes
near significantly associated regions were detected in these three dog breeds, including
ATPase Na+/K+ Transporting Subunit Alpha 4 (ATP1A4), Transformation/Transcription
Domain Associated Protein (TRRAP), and Potassium Inwardly Rectifying Channel Sub-
family J Member 10 (KCNJ10) [17]. However, none have been convincingly identified as
causative mutations.
To extend the identification of potential candidate genes causing deafness in ASCD
we performed a genome-wide association study and whole genome sequencing (WGS) in
deaf ASCD. We identified a unique missense variant in Kruppel-like factor 7 (KLF7) gene
significantly associated with deafness in ASCDs. This variant was absent in 722 dogs of
bioproject PRJN448733 (see below). As KLF7 plays an important role in the nervous system,
is expressed in the inner ear, and seems to be involved in inner ear development [18,19], it
was a convincing candidate for ASCD deafness.
2. Materials and Methods
2.1. Ethical Statement
The collection of dog blood samples was done by S. Sommerlad at the time of BAER
testing. The collection of samples was approved by the “Niedersächsisches Landesamt für
Verbraucherschutz und Lebensmittelsicherheit” (33.19-42502-05-15A506) according to §8a
Abs. 1 Nr. 2 of the TierSchG. All ASCDs were tested and sampled under approval of The
University of Queensland’s Animal Ethics Committee.
2.2. Phenotyping and Samples
Fifty-nine Australian Stumpy Tail Cattle Dogs (Table S1) from a previous study [12]
were used in this study. BAER testing was performed on 59 dogs [20], 28 were normal
hearing dogs and 31 were diagnosed as deaf, of which 10 were bilateral deaf, 12 were
left-sided deaf, and 9 were right-sided deaf (Table S1). Three bilaterally deaf ASCDs
(#217, #253 and #330), and one control dog with normal hearing (#326) were used for
next generation sequencing. Dog #326 was a littermate of #330. These four dogs were
female and red in color; all but #330 had a speckled coat. DNA was extracted using a
salting-out method as described [12]. All samples were pseudonymized using internal
IDs. Furthermore, data from two repository were used in this study. One repository
contain Variant Call Format (VCF) data of 722 canine individuals (https://www.ncbi.
nlm.nih.gov/bioproject/PRJNA448733 (accessed on 24 March 2021)) [21]. It consists of
144 established breeds, 11 samples with mixed breed, 26 samples with unknown breed
status, 104 village and feral dogs from different regions, and 54 wild canids from six species.
An additional dataset consisted of 590 samples including 582 dogs from 126 breeds and
8 wolves (https://www.ebi.ac.uk/ena/data/view/PRJEB32865 (accessed on 24 March
2021)) [22].
2.3. Next Generation Sequencing and Variant Calling
A total of 1.0 µg DNA per ASCD sample was used as input material for the DNA
library preparations. Sequencing libraries were generated using NEBNext® DNA Library
Prep Kit following manufacturer’s recommendations and indices were added to each
sample. The genomic DNA was randomly fragmented to a size of 350bp by shearing, then
DNA fragments were end polished, A-tailed, and ligated with the NEBNext adapter for
Illumina sequencing, and further PCR enriched by P5 and indexed P7 oligos. The PCR
products were purified (AMPure XP system) and resulting libraries were analyzed for size
distribution by Agilent 2100 Bioanalyzer and quantified using real-time PCR. For #217,
#253, #326, #330, a total of 599,770,692, 723,624,660, 743,641,356, 620,101,998 raw reads
were obtained, respectively. Corresponding coverages were around 40× (paired-end reads,
2 × 150 bp).
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Raw sequence data were aligned to dog genome CanFam3.1 using BWA 0.7.17 [23].
SAMtools 1.9 were used for format change and sorting of sequences [24]. Duplicates were
marked by PICARD (http://broadinstitute.github.io/picard/ (accessed on 24 March 2021)).
Variant calling was performed by GATK 4.1.3 with best practice pipeline [25].
2.4. Genome Wide Association Analysis
We used the VCF data obtained in the previous step for GWAS analysis. Three deaf
dogs (#217, #253, #330) were used as cases. As ASCD is utilized for control and herding
of cattle according to its breed standard (http://www.fci.be/Nomenclature/Standards/
351g01-en.pdf (accessed on 24 March 2021)), VCFs of 43 herding dogs from 15 breeds
(Australian Cattle Dog, Bearded Collie, Belgian Malinois, Belgian Sheepdog, Belgian Ter-
vuren, Berger Blanc Suisse, Berger Picard, Border Collie, Bouvier des Flandres, Entlebucher
Sennenhund, Finnish Lapphund, German Shepherd Dog, Pembroke Welsh Corgi, Shetland
Sheepdog, Spanish Water Dog) were extracted from the publicly available 722 canine
VCF repository (https://www.ncbi.nlm.nih.gov/bioproject/PRJNA448733 (accessed on
24 March 2021)) [21]. Sample selection criteria were the same as described [21]. A total of
43 herding dogs and the normal hearing dog #326 were chosen as controls (Table S2). The
VCF files of the 43 herding dogs and 4 ASCDs were merged by BCFtools 1.9 [24]. Filtering
was done using VCFtools 0.1.13 with options –max-alleles 2, –min-alleles 2, –min-meanDP
20, –minQ 20, –minGQ 20, –remove-indels, –max-missing 0.95, –maf 0.05, –hwe 0.001 [26].
After filtering, 857,343 variants remained and were further pruned by Linkage Disequi-
librium with –indep 1000 3 1 function in PLINK 1.90 [27]. The final data set consisted
of 20,656 single nucleotide polymorphisms (SNPs). Principal component analysis (PCA)
was performed using EIGENSOFT package [28]. GEMMA 0.98 was used for association
analysis by case–control setting (3 deaf cases vs. one normal hearing ASCD and 43 herding
dogs as controls) [29]. A univariate linear mixed model with sex, 5 principal components,
and relatedness of 47 dog individuals for corrections was applied for the association test.
Bonferroni threshold −log10P (0.01/20,656) = 6.32 was utilized. Qqman package was used
to generate Manhattan and quantile–quantile (QQ) plots [30]. The genomic inflation factor
lambda was calculated with formula lambda = median (qchisq(1-p, 1))/qchisq(0.5, 1) where
p is a vector of p values.
2.5. Next Generation Sequencing Data Analysis for Identification of Associated Variants
Data after variant calling were analyzed with SNP & Variation Suite 8.8.3 (Golden
Helix Inc., Bozeman, MT, USA). SNPs and indels were set to missing with read depth ≤ 10,
genotype quality ≤ 15, alt read ratios for Ref_Ref ≥ 0.15, Ref_Alt outside 0.3 to 0.7,
Alt_Alt ≤ 0.85. Variants were analyzed using autosomal recessive and dominant models,
respectively. In the autosomal recessive filtering model, 3 deaf ASCDs were set as Alt_Alt,
control ASCD as Ref_Ref or Alt_Ref. In the autosomal dominant filtering model, the
3 deaf ASCDs were set as Alt_Alt or Alt_Ref and controls as Ref_Ref. To further narrow
the range of candidate variants, we compared the common variants of deaf ASCDs with
722 canine genomes to identify private variants. The shared variants in the three deaf dogs
were filtered by BCFtools 1.9 with ‘isec’ option. Private variants were annotated using
SnpEFF software [31] to determine high (loss of function) and moderate (missense) impact
variants (Ensembl transcripts release 101). These functional variants were further checked
by Integrative Genome Viewer (IGV) software to obtain real high quality variants [32].
Variant effects were predicted by SIFT [33], PolyPhen-2 [34], and PROVEAN [35].
2.6. Genotyping of KLF7 Variant in Australian Stumpy Tail Cattle Dogs
Targeted genotyping of the KLF7 missense variant was performed in 59 ASCDs by
PCR amplification using primers cfa_KLF7_Ex3_F (5′-AGACTCTCTCAGCCGTGGAT-
3′) and cfa_KLF7_Ex3_R (5′-GGCCAACTTGTACCACTACCT-3′), resulting in a 295 bp
fragment. Genotyping of PCR products were implemented by RFLP analysis after cleavage
with the restriction enzyme HinP1I (NEB). The wild type allele was cleaved into two
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fragments, 236 bp and 59 bp, while the homozygous mutant remained uncut. Frequency
distribution for alleles and genotypes was calculated using Fisher’s Exact Test in these
59 ASCDs. Allelic and genotypic odds ratios were calculated according to [36].
2.7. Investigation of Human Deafness Genes in 3 Deaf Australian Stumpy Tail Cattle Dogs
Human hearing loss or deafness genes were queried using online software GLAD4U
with “hearing loss” and/or “deafness” as keywords [37]. After combining the three query
results, 346 genes were chosen for further analysis (Table S3). The variants of these gene
regions (including 1000 bp up- and downstream regions) were extracted by BCFtools from
VCF files of the three deaf ASCDs and annotated by SnpEFF software. Variants with
high (loss of function) and moderate (missense) impacts were selected for further analysis
(Ensembl transcripts release 101). The genotype information of the chosen variants was
further checked in 722 canines.
3. Results
3.1. Genome Wide Association Analysis
The analysis was done using three bilateral deaf female dogs from three different litters.
The hearing status of the individuals determined using BAER is shown in Tables 1 and S1.
Table 1. BAER (brainstem auditory evoked response) results of 4 Australian Stumpy Tail Cattle Dogs
(ASCDs).
ID Gender Coat Colour BAER Test Results
217 Female Red speckled Bilaterally Deaf
253 Female Red speckled Bilaterally Deaf
330 Female Red Bilaterally Deaf
326 Female Red speckled Normal Hearing
The three affected ASCDs were compared with 44 control dogs. 13 SNPs on 6 chro-
mosomes (CFA3, 8, 17, 23, 28, 37) above the Bonferroni significance level were identified.
The QQ-plot indicated that some associations might be due to population substructure.
Associated SNPs are shown in Figure 1 and summarized in Table 2. The majority of the
significantly associated SNPs (7/13) were located on CFA37 including SNP chr37:44793
(position according to CanFam3.1) with the highest −log10p-value = 20.02. A search for
large structural variants (SVs) flanking the significantly associated regions on CFA3, 8, 17,
23, 28, and 37 using IGV was unsuccessful.
Table 2. Significantly associated SNPs above Bonferroni significance threshold (6.32).
CFA Position p-Value Nearby Genes Distance (bp)
3 90,987,932 2.67 × 10−8 LCORL 186,575
8 62,032,863 5.93 × 10−13 DGLUCY 19,884
17 1,977,343 1.73 × 10−7 EIPR1 0
17 9,456,133 2.34 × 10−15 TRIB2 204,307
23 50,096,314 3.04 × 10−7 KCNAB1 0
28 21,516 4.50 × 10−9 PTPN20 42,882
37 13,393 2.04 × 10−7 WDR75 144,007
37 44,793 9.54 × 10−21 WDR75 112,607
37 80,438 1.36 × 10−9 WDR75 76,962
37 16,399,127 2.66 × 10−8 CRYGD 25,757
37 22,102,392 6.48 × 10−10 ABCA12 34,340
37 22,579,983 2.93 × 10−7 FN1 57,573
37 22,711,697 1.10 × 10−8 FN1 189,287
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Figure 1. Manhattan and quantile–quantile (QQ) plots illustrating deafness associated chromosomal
regions. (a) The Manhattan plot shows on the y-axis the negative log-base-10 of the p value for each
of the polymorphisms in the genome (along the x-axis), when tested for differences in frequency
between 3 bilateral deaf dogs (cases) and 44 controls (1 × ASCD, 43 herding dogs of 15 dog breeds).
The red line indicates the Bonferroni significance threshold (−log10(0.01/20,656) = 6.32). (b) The QQ
plot depicts the distribution of p-values of the genome-wide association study (GWAS) analysis and
genomic inflation factor lambda is 1.20.
3.2. Whole Genome Sequencing Reveals Four Potential Variants
To further locate the candidate variants, next generation sequencing was performed in
3 deaf ASCDs (#217, #253, #330) and 1 normal hearing ASCD (#326). After quality control, a
total of 4,208,002 SNPs and 2,298,760 indels were detected. According to previous deafness
studies, sequence data were initially analyzed using a recessive model of inheritance. Using
this model, 129,383 SNPs and 51,942 indels were detected. Using only variants that had
been annotated and verified as mRNA transcripts (Ensembl release 101), 338 SNPs and
523 indels remained (Table S4). After filtering these variants against the 722 dog database,
none of the homozygous Alt_Alt genotypes were exclusively present in the deaf ASCDs
(Table S4). As there were no reports about such a high prevalence of deafness in the
722 control dogs and it can be assumed that the majority of the controls were hearing, these
variants were presumably not causative.
As no associated variants were found using the recessive inheritance model, a dom-
inant inheritance model was applied. In this analysis, private variants only present in
the three deaf ASCDs (Alt_Alt and Alt_Ref) compared to the 722 controls (Ref_Ref) were
filtered, resulting in 270,980 SNPs and 351,927 indels. After quality control and functional
annotating, 167 protein-changing variants (58 SNPs and 109 indels) remained (Table S5).
These variants were further filtered against #326 (normal hearing littermate of #330) assum-
ing that this dog should be homozygous wild type under the supposed model. After this
step, four missense variants remained as potential causative candidates (Table 3). Within
the 722 control dogs, no homozygous Alt_Alt or heterozygous carriers were detected for
these 4 missense variants. In an additional dataset consisting of 590 dog samples, only two
heterozygous individuals (Brussels Griffon dogs) were determined for the Microtubule as-
sociated protein 6 (MAP6) gene variant. To deduce which of the variants could be causative
for deafness, protein function prediction tools were used. As shown in Table 4 only the
variants in Heart development protein with EGF like domains 1 (HEG1) and KLF7 were
predicted to be deleterious by at least two of the prediction tools.
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Table 3. Genotype information of four potential causative variants for ASCD deafness.
Chr HGVS Genome Position (a) Variant Type Gene (b) #217 #253 #330 #326
13 NC_006595.3:g.60805542 C>T missense variant GC C_T C_T C_T C_C
21 NC_006603.3:g.23019999 C>T missense variant MAP6 C_T C_T C_T C_C
33 NC_006615.3:g.28028412 G>C missense variant HEG1 G_C G_C G_C G_G
37 NC_006619.3:g.15562684 G>A missense variant KLF7 A_A A_A A_G G_G
(a) Positions according to CanFam3.1; (b) GC: GC vitamin D binding protein, MAP6: Microtubule associated protein 6, HEG1: Heart
development protein with EGF like domains 1, KLF7: Kruppel-like factor 7.
Table 4. Variant effect predicted by SIFT, PolyPhen-2, and PROVEAN.
Gene Amino Acid Exchange SIFT Polyphen-2 PROVEAN
GC p.Gly389Rrg Tolerated Benign Neutral
MAP6 p.Arg486Cys Affect protein function Benign Neutral
HEG1 p.His531Asp Affect protein function Unknown Deleterious
KLF7 p.Leu173Phe Affect protein function Possibly damaging Neutral
SIFT: https://sift.bii.a-star.edu.sg (accessed on 24 March 2021), Polyphen-2: http://genetics.bwh.harvard.edu/pph2/index.shtml (accessed
on 24 March 2021), PROVEAN: http://provean.jcvi.org/index.php (accessed on 24 March 2021).
To further confirm the causative possibilities of the two remaining variants, their
amino acid conservation was analyzed in the same 7 species. The missense variant in HEG1
gene (NC_006615.3: g.28028412G>C) resulted in an amino acid exchange of p.His531Asp
(XP_022269716.1). In KLF7 gene (NC_006619.3: g.15562684G>A), the variant led to an
exchange of p.Leu173Phe (XP_022270984.1). Especially in KFL7, the amino acid position
seems to be highly conserved across several different species, as shown in Figure 2.
Figure 2. Cross-species comparison of variant amino acid positions in HEG1 and KLF7. Partial
protein sequences of HEG1 (a) and KLF7 (b) flanking the variant amino acid positions were aligned
using ClustalW (https://www.ebi.ac.uk/Tools/msa/clustalo/ (accessed on 24 March 2021)). The
variant positions are highlighted with a red arrow. Residual color scheme was referred from [38],
sequence logos are shown according to [39].
3.3. Genotyping of KLF7 Variant in ASCDs
To verify the association of the KLF7 variant with ASCD congenital deafness, 27 nor-
mal hearing and 28 deaf ASCDs (21 unilaterally and 7 bilaterally deaf dogs) were used to
investigate the KLF7 variant genotype distribution. As summarized in Table 5, 59 ASCDs
including the 4 whole genome sequenced dogs were used to check the association of the
KLF7 missense variant with ASCD deafness. Four dogs were homozygous carriers (A_A)
and 14 heterozygous (A_G) among the 31 deaf ASCDs. Within the 28 normal hearing AS-
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CDs, 5 heterozygous and one homozygous carrier were detected. The penetrance of ASCD
deafness was calculated to be 0.75. As determined by Fisher’s exact test, homozygosity
for the KLF7 variant was significantly associated with congenital deafness (p = 0.014). The
odds ratioAA = 6.8 (95% CI [0.68, 67.25]), i.e., homozygous carriers are 6.8 times more likely
to be deaf than wild type.
Table 5. Genotype distribution of KLF7 variant in 31 deaf and 28 normal hearing ASCDs dogs.
Phenotype G_G A_G A_A Total Number P (c)
Unilaterally deaf 10 10 1 21 0.054
Bilaterally deaf 3 4 3 10 0.010
Deafness (uni (a) + bi (b)) 13 14 4 31 0.014
Normal hearing 22 5 1 28
(a) uni: Unilaterally deaf; (b) bi: Bilaterally deaf; (c) p-value using Fisher’s exact test.
4. Discussion
Deafness is a common disorder among dogs, and the observed prevalence is highest in
Dalmatians (29.9%) [3] and 17.8% in ASCD [12]. Even selective breeding based on deafness
phenotyping decreased the prevalence in Dalmatians only to 17.8% [40]. Several other
dog breeds also show rather high prevalence rates (>10%), e.g., Australian Cattle Dog and
Bull Terrier [3]. To accelerate the decline of overall prevalence of congenital sensorineural
deafness, it would be important to identify the genetic cause of the disorder to enable
informed breeding.
We used four ASCD DNA samples from a previous study of deafness in Australian
Stumpy Tail Cattle Dogs for GWAS and WGS analysis. The previous study used a genome
screen with 325 microsatellite (290 were used for linkage mapping) to determine a sig-
nificantly linked deafness region on CFA10 [12]. However, SOX10, the only potential
candidate gene in this region, had to be excluded, as it did not harbor any causative vari-
ants. Another promising candidate in the CFA10 region, i.e., Trio- and f-actin-binding
protein (TRIOBP), had also to be excluded. In the above mentioned study, deafness was
reported to be autosomal recessive inherited with incomplete penetrance [12]. As shown
before, GWAS with multiple breeds can improve the accuracy of causative variant map-
ping [41,42]. Our analysis provided evidence for at least six highly associated chromosomal
regions. However, due to the small number of affected dogs, some associated regions
might have resulted from the close relationship of the dogs. This can be seen in the QQ-plot
which showed convincing evidence for an association with some indication of a population
substructure. In our study, more than half of the significant associated SNPs (7 out of
13) were located on CFA37, including the most significantly related SNP (chr37:44793,
p = 9.54 × 10−21). In a recent study of Dalmatian deafness, signals were also detected in
this region [17]. However, there was no associated peak on CFA37 reported in the previous
microsatellite-based study in ASCD. A possible explanation could be that there were only
five microsatellite markers on CFA37, one of which had a low degree of polymorphism
(3 alleles, PIC 0.5) [12]. This might have been insufficient to detect associations on this
chromosome. An alternative explanation is that ASCD deafness may be heterogeneous.
There may be more than one variant causing congenital deafness in this breed, and using
limited family associations may reveal private mutations. Further genotyping analysis in a
wider range of affected (28) and unaffected (27) ASCDs revealed that the KLF7 missense
variant was still significantly associated with congenital deafness (Table 5). Furthermore,
the penetrance of deafness in ASCD calculated based on the KLF7 variant was 0.75, which
was in agreement with the previously calculated penetrance of 0.72 [12]. Altered allele
(A) frequency is 24.58% (Table 5). If we take penetrance into consideration, the deafness
frequency is (24.58% × 0.75) = 18.4%, which is also close to the previous investigation of
17.8% overall ASCD breed deafness frequency [12]. Several homozygous wild type indi-
viduals were detected among the deaf ASCDs suggesting additional genetic risk factors.
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This was not surprising, as canine congenital deafness seems to be a complex disorder and
different regions were detected in other GWASs for deafness so far [17].
According to our GWAS, functional relationships with deafness of genes near the
significantly associated loci on most chromosomes were unapparent (Table 2). Only the
region on CFA37 was further supported by WGS. In the initial GWAS 651 variants on chro-
mosome 37 (between CFA37:7217 to CFA37:30803691) were identified (Figure 1). Variant
CFA37:15503029T>C with a p-value of 8.61 × 10−6 was only 12,534 bp distant from KLF7.
To evaluate LD over-pruning and potential effects on resolution, we repeated the GWAS
using less stringent pruning parameters (–indep 1000 5 4). This increased the number
of associated variants to 60,746. In agreement with the previous analysis, a variant with
−log10p-value = 14.68 at position CFA37:15463045 remained in the vicinity of KLF7 (Table
S6) and a significantly associated region spanning from CFA37:15463045 to CFA37:16433709
was detected harboring KLF7 (CFA37:15515563-15607345). As expected, a further reduc-
tion of pruning stringency resulted in more chromosomal regions above the significant
threshold (Figure S1). However, especially on CFA10, no significantly associated variants
were identified.
In addition, we applied whole genome sequencing of the deaf dogs and used a
large number of available canine whole genome sequence data as controls to improve
the accuracy and efficiency of causative variant identification. Several GWAS of canine
complex hereditary deafness failed to identify causative variants with the exception of
two associated genes (MYO7A, PTPRQ) causative for a specific form of canine congenital
bilateral deafness with vestibular disease [14,15].
For next generation sequence analysis in the present study, functional variants within
coding regions were primarily considered due to their direct impact on protein function [43].
We filtered all variants using an autosomal recessive model, however, no functional variants
fulfilled this mode of inheritance. Again, the chromosomal region 1 Mb up- and down-
stream of SOX10 (CFA10:25680441-27690530) was checked using IGV, but no deafness
associated variants including larger structural variants were identified. After WGS analysis
and variant effect prediction, only two missense variants within HEG1 and KLF7 remained.
HEG1 is involved in cardiovascular development [44] and therefore seemed unlikely to be
involved in the development of deafness. However, the candidate variant (NC_006619.3:
g.15562684G>A) in KLF7 (CFA37:15515563-15607345) was close to the significantly associ-
ated SNP CFA37:16399127 (p = 2.66 × 10−8) (Table 2). KLF7 is a zinc finger transcription
factor and has been reported to play a role in the nervous system and is vital for neu-
ronal morphogenesis that could function in axon outgrowth [18]. KLF7 was suggested to
have potential functions in neurogenesis of mice, like neuronal differentiation and matu-
ration [45]. KLF7 was also found to promote axon regeneration [46]. Furthermore, KLF7
is required for the development of sensory neurons [47], and it has been reported to play
roles in neurotransmission and synaptic vesicle trafficking [48]. These two processes have
important influences on the auditory system, and therefore disruption of KLF7 could lead
to hearing impairment and dysfunction [49]. Indeed, KLF7 was confirmed to be expressed
in the otic placode which will develop into ears, indicating KLF7 could have an effect on ear
development [19]. KLF7 was also detected to be a fibroblast growth factor (FGF) responsive
factor in ear progenitor induction processes, which implies it may be involved in early ear
induction [50]. KLF7 has been considered as one high quality candidate gene for human
branchio-oto-renal syndrome, which is an autosomal dominant disease with hearing loss
as one clinical sign [51]. KLF7 was the nearby gene (50,519 bp distance) of one significant
signal in adult hearing difficulty GWAS [52]. One recent GWAS of hearing-related traits
with up to 330,759 individuals (UK Biobank) revealed 31 significant genomic risk loci
for adult hearing difficulty, KLF7 was also detected to be significantly associated [53].
Furthermore, the protein sequence segments surrounding KLF7 variant are much more
conserved than that of HEG1 among the same 7 species (Figure 2). Recently, KLF7 has been
reported to directly regulate GATA Binding Protein 3 (GATA3) expression [54]. GATA3
is expressed in the otic placode and is involved in inner ear development [55]. Though
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the interaction between KLF7 and GATA3 was reported in chicken adipogenesis, KLF7
is quite conserved among several species (Figure 2). Knockdown of Paired Box Protein
Pax-2 (PAX2) (inner ear development gene) led to a significant up-regulation of both KLF7
and GATA3 expression [19], which implies KLF7 and GATA3 are probably involved in the
same pathway. Furthermore, GATA3 is the causative gene for human hypoparathyroidism,
deafness, and renal dysplasia (HDR) syndrome [56]. Therefore, KLF7 could interact with
GATA3 during the development of inner ear, and defects in KLF7 could affect GATA3
normal expression patterns in otic placode. This may be a potential cause of hearing loss in
ASCD cases. The incomplete penetrance presented by the KLF7 variant in deafness may be
related to its role as a transcription factor that is involved in a specific part of the hearing
pathway. Our findings could provide clues for the functional analysis of the KLF7 in inner
ear development. Functional analysis of KLF7 regarding ear development may provide
further evidence for its role in deafness.
Another intriguing possible pathway is suggested by the finding of a KLF binding
site upstream of the M promoter of Microphthalmia-associated transcription factor (M-
MITF) that induces gene expression changes in humans [57]. Although the aforementioned
study was related to melanoma development, M-MITF has been identified as the locus
responsible for white coat patterning in dogs [58]. Hereditary deafness has been reported
to be associated with white pigmentation in several species, e.g., by affecting M-MITF
isoform expression in pigs [59] and cows [60] as well as humans [61]. Canine deafness was
also linked with white pigmentation due to the merle and piebald locus [62]. Congenital
sensorineural deafness of English Bull Terrier is predominant in individuals with white
coat color [63]. Similarly, congenital hereditary sensorineural deafness in the Australian
Cattle Dog was negatively associated with bilateral facial masks, also individuals with
pigmented body patches showed a lower risk of deafness [64]. An inverse association
of pigmented head patches and congenital sensorineural deafness was also observed
in Dalmatians, while on the other hand, a positive correlation was detected with blue
irises [65–71]. In ASCD, congenital sensorineural deafness was moderately significant
associated with red/blue coat color, but not with speckling and facial masks [12]. However,
no functional alterations in genes related to coat color or pigmentation were detected
after filtering for case–control setting in the present study. Thus far, no causative variants
within genes involved in pigmentation have been identified in canine deafness. Some
pigmentation genes have actually been excluded as candidates in different dog breeds, e.g.,
c-Kit (KIT) and melanocyte protein 17 (SILV) [72,73]. An alternative explanation is that
deafness caused by dysfunctions of other biological processes may be more common, such
as ear development and morphogenesis. This is highly relevant in the Gene Ontology (GO)
category analysis of potential canine hereditary deafness genes [2]. In our study, KLF7 was
reported to participate in inner ear development processes [50]. There is good evidence here
that the KLF7 variant contributes to deafness, but the genotyping data supports the view
that this is a multigene/multifactorial disease, and so this is one contributing mutation.
5. Conclusions
In summary, a missense variant within KLF7 gene has been identified to be significantly
associated with congenital deafness in Australian Stumpy Tail Cattle Dogs. As KLF7 gene
was reported to be expressed in the inner ear and associated with human hearing difficulties,
our findings could provide clues for further elucidating novel genetic causes for human
hearing loss.
Supplementary Materials: The following are available online at https://www.mdpi.com/2073-4
425/12/4/467/s1, Figure S1. Manhattan and QQ plots of the Genome Wide Association Analysis
(GWAS) for ASCD deafness. Table S1: KLF7 variant genotypes of 59 ASCDs. Table S2: Dog breeds
of herding group. Table S3: Human deafness related genes. Table S4: Variants of recessive inher-
itance model and annotated with Ensembl release 101. Table S5: Private variants and annotated
with Ensembl release 101. Table S6: Significantly associated SNPs above Bonferroni significance
threshold (6.78).
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Figure S1. Manhattan and QQ plots of the Genome Wide Association Analysis (GWAS) for ASCD deafness. 
(a) Association of 60,746 variants with bilateral deafness in 47 dogs (3 cases and 44 controls). The plot 
shows the -log10p-values for all variants. 60,746 were remained after pruning by Linkage Disequilibrium 
with parameters --indep 1000 5 4. The red horizontal line represents the Bonferroni genome-wide 
significance threshold of −log10(0.01/60,746) = 6.78. (b) Quantile-quantile (QQ) plot showed the 
observed -log10p-values in the black curve, the red line indicated the distribution of expected -log10p-





















 CHAPTER 5 
 
 




1 Significance of the research  
This thesis describes potential candidate variants and genes for three disorders, namely an 
idiopathic infertility in Holstein bull, hemophilia B in Hovawart and congenital deafness in 
ASCD, and attempts to shed light on their causal principles from a genetic perspective. 
 
Focusing on bull fertility is an important issue in cattle breeding, especially in the context of 
rapidly declining fertility due to intense selection for productive traits. Cattle are an important 
component of farm animal, primarily providing milk for humans. Therefore, identifying a 
candidate causal variant in ABHD16B for idiopathic infertility in bull can improve cattle 
breeding by controlling the proportion of unfavorable variants in the herd. 
 
Hemophilia B is a recessive, X-linked bleeding disorder that severely affects the normal life 
of patients and the welfare of dogs. We have elucidated the causative variant of a hemophilia 
B Leyden found in a Hovawart family, providing theoretical support for overcoming canine 
hemophilia B. 
 
We have identified a potential candidate variant in KLF7 that has a penetrance of 0.75 for the 
congenital deafness in ASCD. Dogs are good models for complex disease studies, such as 
deafness with high heterogeneity, because dogs have a simplified genetic background and 
high linkage disequilibrium (LD). 
 
2 Biological studies in animals help humans understand themselves 
Within the past 20 years, the field of genetics and genomics has undergone extraordinary 
changes due to the development of new technologies, large-scale resources, and 
computational approaches [1]. The year 2001 marked a new milestone with the publication of 
the sketch of the human genome [2]. By 2003, the human genome was declared complete, yet 
there were still many gaps that had not been filled [3]. Initial analysis revealed that about 50% 
of the human genome was made up of repetitive sequences [4]. Scientists analyzed the coding 
protein sequences by RNA expression data and found about 40,000 protein-coding genes [5]. 
Subsequently, the genomes of mammals such as mouse [6], rat [7] and dog [8] were published 
and scientists realized that gene function could be better analyzed using comparative 
genomics [1]. For example, using conserved synthesis among four mammalian species - 
human, mouse, rat and dog - scientists revised the number of mammalian genes to 




inform the resolution of similar diseases in humans. There are more than 350 canine diseases 
that are analogous to humans [9]. Some of these diseases are caused by the same abnormal 
gene products, such as enzyme, receptor, transporter or structural protein [10]. Many diseases 
similar to humans have been identified in dogs, such as canine systemic lupus erythematosus 
[11], skeletal developmental disorders [12], osteosarcoma [13], and canine compulsive 
disorder [14, 15]. 
  
3 Candidate Gene Targeting 
3.1 Phenotype definition and measurement 
Detailed phenotype description, rigorous phenotype definition and classification are the basis 
of biological research, especially for the complex traits. Some phenotypic heterogeneity 
(diverse disease manifestations) is caused by genetic heterogeneity (different sets of genetic 
factors for each disease subtype). Careful selection of cases can minimize the impact of 
misclassification due to possible phenotypic heterogeneity, and enrich the genetic components 
of sub-phenotype. This step can improve the ability to detect genetic variants associated with 
specific sub-phenotypes [16]. 
 
Male infertility is a multifactorial pathological condition with a highly complex genetic 
background. The histological phenotypes of semen and testis exhibit great heterogeneity, and 
about 2,000 genes are involved in human spermatogenesis [17]. Common factors that 
contribute to male infertility include azoospermia, oligospermia, asthenospermia, and 
abnormal morphology of testis and spermatozoa, which account for a substantial fraction of 
causative factors (reviewed by [17]). However, there are still many cases with unknown 
etiology. Therefore, discovering novel genetic factors in idiopathic infertility is a key step to 
improve male fertility. In dairy cattle breeding, much less attention has been paid to 
improving bull fertility than to improving cow fertility. But the fact is, widespread 
dissemination of semen among different populations may amplify the impact of individual 
bulls on profitability. In some cases, semen companies may adjust the number of sperms in 
the artificial insemination device to compensate for reduced fertility or suboptimal semen 
parameters [18]. This results in a wide range of fertility in the bull used for breeding. 





3.2 GWAS and WGS 
The first genome-wide association study was published in 2005, which identified the 
association of complement factor H with age-related macular degeneration [20]. This study 
prompted the genetics community to recognize the efficiency and feasibility of GWAS in 
finding variants associated with unknown diseases. With the following explosion of GWAS 
publications, the genetics studies of human complex diseases have entered a new era, and then 
expanded to the field of animals and plants. With the release of the first Bos taurus whole 
genome assembly in 2009 [21] and the availability of commercial genotyping assay [22], a 
large number of GWAS have emerged in the bovine setting. The importance of bull’s 
contribution to reproductive success has been fully demonstrated [23, 24]. However, 
compared with female fertility research, there are very few studies on quantitative trait loci 
(QTL), GWAS or candidate genes for male fertility. Some reviews have summed up data that 
associated with bull fertility traits [25, 26]. Fonseca et al. [26] systematically reviewed the 
genetic mechanisms of bull fertility traits. Spermatic and testicular related traits show a high 
genetic heterogeneity. GWAS related to testicular traits are mostly carried out in beef, and 
more GWAS studies in dairy cattle are about sperm traits. Compared with spermatic traits, 
testicular traits have higher heritability values, easier measurement methods and higher 
correlation with fertility traits, indicating that testicular measurements are a more stable and 
representative measure of beef and dairy cattle fertility. Thus, more GWASs using testicular 
features should be implemented in dairy cattle. In addition to the dominant sperm infertility 
issues, such as motility and morphology defects, idiopathic male subfertility has also been 
reported in Fleckvieh, caused by a loss-of-function mutation in TMEM95 [27]. In chapter 2, 
we described a case of idiopathic male infertility in Holstein cattle with normal sperm 
characteristics but infertility. GWAS analysis determined that the idiopathic infertility was 
related to a region on BTA13. Therefore, AI bulls provide an ideal model system to study the 
relationship between male fertility and genome-wide variation because of their complete 
pedigree records, extensive breeding records and offspring records [28]. 
 
The application of GWAS also has limitations. Compared with rare SNPs, GWAS is easier to 
detect common SNPs with higher statistical power. In addition, because the selection of SNPs 
is guided by LD information rather than function, it is more likely that the SNPs identified by 
GWAS are only surrogate markers for functional variation [16]. Besides, the applicability of 
GWAS results in different populations depends on characters of markers, like allelic 




areas related to interesting traits that are unique to a specific group or shared among multiple 
groups [26]. In the future, GWAS studies can increase the sample sizes, conduct larger studies 
or combine the existing GWAS data set in meta-analyses [16]. 
 
Although GWAS is a powerful tool for identifying genomic regions related to phenotypes, it 
lacks the ability to detect causal variations [29]. As technology advances, WGS becomes 
cheaper and more readily available. Therefore, it can be used to further identify candidate 
disease-causal variants and genes. The depth of coverage and the number of subjects to be 
sequenced need to be considered to increase the possibility of finding potential causal variants 
[29]. In this thesis, the identification of potential candidate variants was done with the help of 
WGS. 
 
4 Post-GWAS era 
4.1 Annotation of candidate variants and genes 
The annotation of candidate causal variants or genes is an important step in revealing how 
they impact function, which requires comprehensive and highly accurate functional genomic 
databases. Currently, a large number of phenotype-associated regions and markers have been 
discovered, but their annotation and functional studies lag behind, especially for animals. 
Therefore, enhancing genomic annotation and increasing the available resources is an ongoing 
research hotspot [30]. For example, the FAANG project aims to establish the exhaustive 
catalogues of regulatory elements in livestock, e.g. the species-specific and tissue-specific 
epigenome maps [31]. FAANG’s preliminary work focused on the generation of the basic data 
for annotation, mainly based on the individual level [32]. The Dog 10k project plans to use 
WGS data from 10,000 canines to improve existing reference genomes from Boxers, to create 
new reference genomes using other canines, and to apply these data to other scientific 
questions [33]. 
 
Commonly used functional analysis approaches for associated regions including identification 
of evolutionary conserved regions, distal regulatory elements (enhancers, silencers, etc.), 
promoter regions, enriched Gene Ontology (GO) terms, metabolic pathways and previously 
annotated related QTLs [26]. Only few risk-associated loci harbor variants that directly affect 
coding sequence [34]. In fact, more genetic risk variants fall within the regulatory regions of 
genes [35]. Some genetic risk variants can control gene expression by regulating cis-




looping, or miRNA recruitment (reviewed by [36]). Many techniques and methods have been 
developed to detect regulatory elements. At first, Chromatin immunoprecipitation (ChIP) was 
used to detect the location of individual transcriptional regulatory sequences [37]. Over time, 
genome-wide location of DNA-bound proteins were identified by ChIP-on-chip and ChIP-seq 
[38], and they have been extended to look at differential methylation and acetylation of 
genomic bases and their binding proteins [39-41]. Transcriptional regulatory elements also 
can be recognized by assays such as histone modification or DNase sensitivity (or 
hypersensitivity) [39, 42-44]. Those methods provide more valuable information than 
studying sequence conservation, because regulatory sequences like enhancers usually lack 
sequence conservation [45], and show cell type [43] and species specificity [46, 47] in 
controlling gene expression. Meanwhile, Chromosome Conformation Capture (3C) [48] and 
derivative methods (4C, 5C, Hi-C and ChIA-PET) [49-54] have made it possible to detect 
chromosome structure in the three-dimensional space of the nucleus. Many combinations of 
regulatory enhancer-enhancer, enhancer-promoter or promoter-promoter have been uncovered 
[55-57]. Hi-C also can be used to detect the topologically associated domains of chromosome 
structure, which helps scientists understand the genomic composition of specific regulatory 
regions in specific tissues [58]. Subsequently, Assay for Transposase-accessible chromatin 
using sequencing (ATAC-seq) was reported to discover open chromatin [59] and was widely 
used for cis-regulatory sequences mapping. It was found that studies based on mixed cell 
populations may lead to the loss of important information, especially in tumors where genetic 
heterogeneity is common [60-62]. The idea of single-cell analysis is proposed, which may 
fundamentally change our view of how multicellular organisms work and give rise to new 
research questions [63]. Therefore, single-cell sequencing technologies were developed to try 
to understand the function of individual cells in their microenvironment. Similarly, single-cell 
analysis has been combined with other techniques in the study of transcriptional regulatory 
elements. For example, single-cell Hi-C was introduced in order to shift the probabilistic 
chromosome conformation averaged from millions of cells towards the resolution of 
chromosome and genome structure in a single cell [64]. Single-cell ATAC-seq (scATAC-seq) 
has been developed by combining with cell indexing or isolation methods, such as the use of 
scTHS-seq [65], microfluidic devices (Fluidigm, C1) [66], nano-well array (ICELL8, Takara 
Bio) [67] or droplet-based platforms [68, 69]. In addition, the Genotype-Tissue Expression 
(GTEx) project (https://www.gtexportal.org/home/) aims to characterize differences in gene 
expression levels in different individuals and different tissues and attempts to link them to 





4.2 Functional verification of candidate variants and genes 
In addition to the high-throughput methods mentioned above, it is essential to verify the 
variation or gene function of a specific disease or phenotype by appropriate molecular 
biological methods. Functional validation of candidate variants is challenging and is often 
achieved with the help of model animals, as samples of cases are often difficult to obtain. 
However, complete experimental validation is the ultimate step to accurately define the 
contribution of a variant or gene to a phenotype or disease. In chapter 2, we have detected the 
protein expression of ABHD16B in testicular parenchyma, ductuli efferentes, and epididymis 
(tail, body, and head), which covers the entire process of spermatogenesis and sperm 
maturation. ABHD16B expression was also detected in the nucleoplasm of Leydig cells. In 
adults, Leydig cells increase the rate of cholesterol translocation to mitochondria, where 
cholesterol is metabolized to androgens [72]. Cholesterol can be derived from the de novo 
synthesis of acetate and is stored in lipid droplets [73], or from the cell membranes of Leydig 
cell [74]. The α/β hydrolase fold domain protein have thought to be involved in lipid 
metabolism and signal transduction [75]. Therefore, a hypothesis was defined that the 
candidate gene ABHD16B affects bull fertility by participating in lipid metabolism during 
spermatogenesis and sperm maturation. We verified this hypothesis by comparing the 
lipidome of the sperm plasma membrane of variant carriers and controls. The results showed 
that several lipid components of sperm membranes displayed significant concentration 
differences, suggesting the important role of ABHD16B in spermatogenesis and sperm 
maturation. During spermatogenesis, the differentiation and maturation of germ cells require 
extensive formation and remodeling of cell membranes. In this process, lipids undergo 
considerable quantitative and qualitative changes [76]. With the migration of sperm in the 
female reproductive tract, the sperm acquires the ability to fertilize accompanied by constant 
changes in lipids [77]. Several key processes such as acrosome reaction and sperm-egg fusion 
are membrane-related events involving exocytosis and membrane fusion [78, 79]. Lipids are 
multifunctional molecules in exocytosis, involved in providing platform for molecular 
interaction, acting as messengers in signal transduction and molecular recognition, and 
defining the shape of membranes [80, 81]. To our knowledge, there is no report about 
ABHD16B protein in reproduction. Our results showed that ABHD16B protein deficiency can 
lead to changes in lipid composition of the sperm plasma membrane, which may be a novel 





4.3 Application and perspective 
In order to meet the growing demand of the world’s population for animal-based food 
products, scientists all over the world are working hard to increase the productivity of 
livestock. Breeding strategies and management practices are developed based on the accurate 
mapping and understanding of the causative or functional variation behind the phenotype. The 
rate of genetic gain in breeding is improved by increasing the accuracy of genomic selection 
or targeted genome editing [82]. 
  
The genomic selection is widely adopted in dairy cattle breeding and is rapidly developing in 
other livestock industries because it can effectively improve genetic progress [83]. Published 
studies have shown that the fertility traits of bulls are low to moderately heritable, indicating 
that the fertility of bulls can be improved through selection [23, 84-86]. For example, a recent 
study found that when the genomic prediction includes the markers with large effect on SCR, 
the predictive ability of Holstein bull fertility was improved [86]. In order to improve the 
prediction accuracy, genetic markers require to be carefully classified by function and more 
powerful and stable prediction models need to be developed [30]. Several studies have been 
proposed to integrate the biological information into genomic prediction, which is an effective 
method to improve the prediction accuracy [87-89]. Therefore, our findings can complement 
the bovine genome annotation information and be further used for genome-based selection. 
The KLF7 variant we identified can be applied to the ASCD breeding to control the 
prevalence of deafness. 
 
Genome editing technologies offer new and exciting opportunities for producing higher 
yielding and healthier livestock. The feasibility of genome editing in breeding is demonstrated 
by (1) rapid fixation of favorable alleles at segregated QTL within breeding populations [90], 
(2) targeted introduction of favorable alleles from other species, strains, or populations into 
closed breeding populations by editing [91], or (3) creation of new alleles with beneficial 
effects based on unbiased genome-wide screening or predictions from a priori biological 
knowledge of the trait in question [30, 82]. A successful example of breeding for disease 
resistance in domestic animals: removal of an exon of the CD163 gene in pigs gave complete 
resistance to reproductive and respiratory syndrome virus [92]. 
 
Furthermore, genome-editing is a good tool for fundamental research and disease treatment 




provide rich phenotypic and molecular models [93]. CRISPR/Cas9 system has been used for 
mutagenesis of specific DNA sequences to reveal the function of regulatory elements that 
were predicted by sequence- and chromatin-based assays [94]. CRISPR/Cas9-based 
acetyltransferases catalyze the acetylation of specific histones, which leads to transcriptional 
activation of target genes from promoters and enhancers [95]. Hemophilia, as a monogenic 
disease, is an ideal target for genome editing methods aimed at correcting defective genes. 
Gene therapy has been used in the treatment of hemophilia B [96]. Delivery of an AAV vector 
encoding ZFN into the mouse liver to correct the donor template to produce high levels of 
factor IX in a murine model of hemophilia B [97]. The development of gene editing 
technology may accelerate the introduction of gene therapy into the routine clinical practice. 
 
Although technology is advancing rapidly and our understanding of biology is deepening, 
humanity still faces enormous challenges. We still have much work to do in food production, 
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